<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">90510</article-id><article-id pub-id-type="doi">10.7554/eLife.90510</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.90510.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Endosomal dysfunction contributes to cerebellar deficits in spinocerebellar ataxia type 6</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-324961"><name><surname>Cook</surname><given-names>Anna A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7654-0212</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-163016"><name><surname>Leung</surname><given-names>Tsz Chui Sophia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2158-4300</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324962"><name><surname>Rice</surname><given-names>Max</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324963"><name><surname>Nachman</surname><given-names>Maya</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-324964"><name><surname>Zadigue-Dube</surname><given-names>Élyse</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-3642"><name><surname>Watt</surname><given-names>Alanna Jean</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6371-6220</contrib-id><email>alanna.watt@mcgill.ca</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01pxwe438</institution-id><institution>Biology Department, McGill University</institution></institution-wrap><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hj8s172</institution-id><institution>Department of Biological Sciences, Columbia University</institution></institution-wrap><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005dvqh91</institution-id><institution>New York University Langone Medical Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Nelson</surname><given-names>Sacha B</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05abbep66</institution-id><institution>Brandeis University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>12</day><month>12</month><year>2023</year></pub-date><volume>12</volume><elocation-id>RP90510</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-07-03"><day>03</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-06-26"><day>26</day><month>06</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.06.26.546542"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-08-18"><day>18</day><month>08</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90510.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-11-09"><day>09</day><month>11</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.90510.2"/></event></pub-history><permissions><copyright-statement>© 2023, Cook et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Cook et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-90510-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-90510-figures-v1.pdf"/><abstract><p>Spinocerebellar ataxia type 6 (SCA6) is a rare disease that is characterized by cerebellar dysfunction. Patients have progressive motor coordination impairment, and postmortem brain tissue reveals degeneration of cerebellar Purkinje cells and a reduced level of cerebellar brain-derived neurotrophic factor (BDNF). However, the pathophysiological changes underlying SCA6 are not fully understood. We carried out RNA-sequencing of cerebellar vermis tissue in a mouse model of SCA6, which revealed widespread dysregulation of genes associated with the endo-lysosomal system. Since disruption to endosomes or lysosomes could contribute to cellular deficits, we examined the endo-lysosomal system in SCA6. We identified alterations in multiple endosomal compartments in the Purkinje cells of SCA6 mice. Early endosomes were enlarged, while the size of the late endosome compartment was reduced. We also found evidence for impaired trafficking of cargo to the lysosomes. As the proper functioning of the endo-lysosomal system is crucial for the sorting and trafficking of signaling molecules, we wondered whether these changes could contribute to previously identified deficits in signaling by BDNF and its receptor tropomyosin kinase B (TrkB) in SCA6. Indeed, we found that the enlarged early endosomes in SCA6 mice accumulated both BDNF and TrkB. Furthermore, TrkB recycling to the cell membrane in recycling endosomes was reduced, and the late endosome transport of BDNF for degradation was impaired. Therefore, mis-trafficking due to aberrant endo-lysosomal transport and function could contribute to SCA6 pathophysiology through alterations to BDNF–TrkB signaling, as well as mishandling of other signaling molecules. Deficits in early endosomes and BDNF localization were rescued by chronic administration of a TrkB agonist, 7,8-dihydroxyflavone, that we have previously shown restores motor coordination and cerebellar TrkB expression. The endo-lysosomal system is thus both a novel locus of pathophysiology in SCA6 and a promising therapeutic target.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>transcriptomics</kwd><kwd>early endosomes</kwd><kwd>lysosome</kwd><kwd>cellular trafficking</kwd><kwd>BDNF–TrkB signaling</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT-153150</award-id><principal-award-recipient><name><surname>Watt</surname><given-names>Alanna Jean</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT-190151</award-id><principal-award-recipient><name><surname>Watt</surname><given-names>Alanna Jean</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT-190129</award-id><principal-award-recipient><name><surname>Watt</surname><given-names>Alanna Jean</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000156</institution-id><institution>Fonds de Recherche du Québec - Santé</institution></institution-wrap></funding-source><award-id>Doctoral Award</award-id><principal-award-recipient><name><surname>Cook</surname><given-names>Anna A</given-names></name><name><surname>Leung</surname><given-names>Tsz Chui Sophia</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004489</institution-id><institution>Mitacs</institution></institution-wrap></funding-source><award-id>Training award</award-id><principal-award-recipient><name><surname>Cook</surname><given-names>Anna A</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008582</institution-id><institution>McGill University</institution></institution-wrap></funding-source><award-id>Science undergraduate research award</award-id><principal-award-recipient><name><surname>Rice</surname><given-names>Max</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100008582</institution-id><institution>McGill University</institution></institution-wrap></funding-source><award-id>Biology research award</award-id><principal-award-recipient><name><surname>Zadigue-Dube</surname><given-names>Élyse</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Changes in the intracellular trafficking of key signaling molecules in endosomes lead to pathophysiology in a rare disease affecting the cerebellum.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Spinocerebellar ataxia type 6 (SCA6) is an inherited ataxia which presently has no cure (<xref ref-type="bibr" rid="bib58">Solodkin and Gomez, 2012</xref>). It is caused by a CAG expansion mutation that generates an expanded polyglutamine tract in the translated protein (<xref ref-type="bibr" rid="bib73">Zhuchenko et al., 1997</xref>). The affected gene is <italic>CACNA1A</italic> (<xref ref-type="bibr" rid="bib73">Zhuchenko et al., 1997</xref>)<italic>,</italic> which encodes both the alpha subunit of voltage-gated calcium P/Q channels and a putative transcription factor (<xref ref-type="bibr" rid="bib21">Du et al., 2019</xref>; <xref ref-type="bibr" rid="bib20">Du et al., 2013</xref>). The cellular dysfunction giving rise to disease in SCA6 is poorly understood. Here, we examine the role of the endo-lysosomal system in SCA6 pathophysiology.</p><p>The endo-lysosomal system comprises of a series of membrane-bound compartments that sort and transport endocytosed molecules destined for recycling or degradation (<xref ref-type="fig" rid="fig1">Figure 1a</xref>; <xref ref-type="bibr" rid="bib26">Hu et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Huotari and Helenius, 2011</xref>). These compartments are highly dynamic and regularly interact and fuse with each other as cargo is sorted and trafficked. Each compartment has a characteristic pH mediated by ATP-dependent acidification (<xref ref-type="bibr" rid="bib26">Hu et al., 2015</xref>), and is characterized by the presence of specific proteins that allow them to carry out their functions. Rab GTPases regulate trafficking of cargo, and each compartment is associated with a specific signature of Rab family members (<xref ref-type="bibr" rid="bib60">Stenmark, 2009</xref>). Endocytosed cargo arrives first at the early endosomes (<xref ref-type="bibr" rid="bib41">Ludwig et al., 1991</xref>), where the slightly acidic pH leads to dissociation of ligands from their receptors. Here, the cargo will undergo sorting: those that are destined for recycling such as receptors, will be returned to the cell surface. Cargo that is destined for further sorting or degradation will move to the late endosomes, which are characterized by an increasingly acidic pH and increased enzymatic activity (<xref ref-type="bibr" rid="bib26">Hu et al., 2015</xref>; <xref ref-type="bibr" rid="bib27">Huotari and Helenius, 2011</xref>). The lysosome is the final destination of cargo that is to be degraded. This compartment is the most acidic and contains over 50 hydrolases that carry out rapid degradation of cargo (<xref ref-type="bibr" rid="bib19">de Duve, 2005</xref>; <xref ref-type="bibr" rid="bib37">Lawrence and Zoncu, 2019</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Endo-lysosomal genes are dysregulated in the spinocerebellar ataxia type 6 (SCA6) cerebellum.</title><p>(<bold>a</bold>) Schematic showing the endo-lysosomal system. (<bold>b</bold>) Heat map showing relative expression of endo-lysosomal-associated transcripts in the cerebellum of five wildtype (WT) and five SCA6 mice (1 column per mouse). Genes are separated into groups based on their gene ontology categorization (GO term Endosome and Lysosome; the group ‘Endolysosome’ denotes genes that belong to both GO term categories), only genes with an adjusted p value &lt;0.05 are shown.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Normalized reads of endolysosomal genes.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90510-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig1-v1.tif"/></fig><p>Endosome dysfunction plays a role in the pathophysiology of several neurological diseases. A notable example is Alzheimer’s disease, where postmortem brain tissue from patients displays increased early endosome size and accumulation of cargo (<xref ref-type="bibr" rid="bib9">Cataldo et al., 2004</xref>; <xref ref-type="bibr" rid="bib8">Cataldo et al., 2000</xref>; <xref ref-type="bibr" rid="bib7">Cataldo et al., 1997</xref>; <xref ref-type="bibr" rid="bib62">Tate and Mathews, 2006</xref>). Similar early endosome changes are seen in Down syndrome (<xref ref-type="bibr" rid="bib8">Cataldo et al., 2000</xref>) and Niemann Pick C (<xref ref-type="bibr" rid="bib30">Jin et al., 2004</xref>; <xref ref-type="bibr" rid="bib34">Kim et al., 2023</xref>). In the cerebellum, endo-lysosomal dysfunction can lead to cerebellar dysfunction (<xref ref-type="bibr" rid="bib1">Akizu et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Mannan et al., 2004</xref>; <xref ref-type="bibr" rid="bib61">Sterling et al., 2023</xref>; <xref ref-type="bibr" rid="bib64">Vanier, 2010</xref>), and has been identified in cerebellar diseases with diverse disease-causing mechanisms (<xref ref-type="bibr" rid="bib2">Alves et al., 2014</xref>; <xref ref-type="bibr" rid="bib72">Zhu et al., 2022</xref>). As endosomes are the site of disassociation of ligands from their receptors, mediating both the recycling of receptors back to the cell surface and the sorting of ligands for further signaling or degradation, dysfunction can disrupt signaling pathways due to mis-trafficking of signaling molecules.</p><p>Previously, lysosomal accumulation of protein aggregates has been observed in a mouse model of SCA6 (118Q) that features a hyperexpanded polyglutamine repeat (<xref ref-type="bibr" rid="bib63">Unno et al., 2012</xref>). This suggests that lysosomes may play a role in SCA6. Cerebellar pathology in this model was worsened when lysosomal function was impaired by the loss of the lysosomal enzyme cathepsin B (<xref ref-type="bibr" rid="bib63">Unno et al., 2012</xref>). However, it has been unknown whether endo-lysosomal pathway dysregulation is implicated in the natural disease progression of SCA6, or whether other endosomal compartments may be involved.</p><p>We have recently found that deficits in the brain-derived neurotrophic factor (BDNF)–tropomyosin kinase B (TrkB)–Akt signaling pathway contribute to SCA6 pathophysiology (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>), with both BDNF and TrkB expression reduced in the cerebellar vermis. However, the underlying causes of the reduced levels of BDNF and TrkB remained unknown. Since both BDNF and TrkB are dynamically trafficked through the endo-lysosomal system (<xref ref-type="bibr" rid="bib47">Moya-Alvarado et al., 2023</xref>; <xref ref-type="bibr" rid="bib46">Moya-Alvarado et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">Yamashita and Kuruvilla, 2016</xref>), we wondered whether dysfunction in this system could underlie BDNF and/or TrkB mislocalization, contributing to subsequent cellular dysfunction in SCA6.</p><p>To address whether alterations in the endo-lysosomal system give rise to cellular dysfunction in SCA6, we examined endo-lysosomal compartments in the cerebellum of male and female SCA6<sup>84Q/84Q</sup> mice (referred to as SCA6 mice) in the early stages of SCA6 progression. In addition to observing abnormalities in endosomal compartments, we found that BDNF and its receptor TrkB accumulated in early endosomes instead of undergoing normal sorting and recycling. These abnormalities were present in SCA6 mice between 7 and 12 months of age, coincident with the onset of motor impairment and long before Purkinje cell degeneration (<xref ref-type="bibr" rid="bib28">Jayabal et al., 2015</xref>). These changes therefore represent an early driver of SCA6 pathology. We were able to rescue the deficits in early endosomes with chronic administration of the TrkB agonist 7,8-dihydroxyflavone (7,8-DHF), a treatment that we previously found could also rescue behavioral and Purkinje cell firing deficits in the SCA6 mice. Our findings argue that endo-lysosomal dysfunction is a novel locus of pathophysiology in spinocerebellar ataxia and a potential therapeutic target to investigate further.</p></sec><sec id="s2" sec-type="results"><title>Results</title><p>The endo-lysosomal system (<xref ref-type="fig" rid="fig1">Figure 1a</xref>) is critical for proper cellular function and its dysregulation is associated with mis-trafficking of important cargo. Here, we address whether endo-lysosomal dysfunction contributes to SCA6, using a mouse model (SCA6<sup>84Q/84Q</sup> mice, referred to as SCA6 mice) that robustly models the mid-life onset of motor deficits and cerebellar dysfunction seen in SCA6 patients (<xref ref-type="bibr" rid="bib28">Jayabal et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Watase et al., 2008</xref>). We have previously shown that around 7 months of age, SCA6 mice develop deficits in motor coordination that progressively worsen (<xref ref-type="bibr" rid="bib28">Jayabal et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Jayabal et al., 2016</xref>) and display cellular deficits, including aberrant Purkinje cell firing and disrupted BDNF–TrkB signaling (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>; <xref ref-type="bibr" rid="bib11">Chang et al., 2022</xref>; <xref ref-type="bibr" rid="bib29">Jayabal et al., 2016</xref>). The cellular alterations that lead to the reduction of BDNF and TrkB in the SCA6 cerebellum remained unknown, so we conducted further investigation into potential causes.</p><p>We carried out RNA-sequencing on cerebellar vermis tissue from 12-month-old litter-matched wildtype (WT) and SCA6 mice (<italic>N</italic> = 5 for each genotype) during the course of another investigation. This sequencing revealed that many genes involved in the endo-lysosomal system, as defined by the gene ontology (GO:CC) terms ‘Endosome’ (GO:0005768) and ‘Lysosome’ (GO:0005764), were significantly dysregulated in the SCA6 cerebellum (<xref ref-type="fig" rid="fig1">Figure 1b</xref>, p<sub>adj</sub> &lt; 0.05, see <xref ref-type="table" rid="table1">Table 1</xref> for a full list). The expression levels of these genes were altered by between 10% and 200% in SCA6 compared to WT. Endosomal genes were found to be both up- and downregulated in SCA6, but the genes covered by the Lysosome GO term were mostly upregulated compared to WT. The affected genes are associated with multiple endosomal compartments, meaning that the cellular consequences could be wide reaching. We therefore aimed to determine whether different compartments of the endo-lysosomal system (<xref ref-type="fig" rid="fig1">Figure 1a</xref>) are altered in the cerebellum of SCA6 mice, and whether this could contribute to previously described BDNF and TrkB deficits, via mis-trafficking through the endo-lysosomal system.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>List of differentially expressed genes (DEGs) in Endosome and Lysosome pathways.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Gene name</th><th align="left" valign="bottom">Gene ID</th><th align="left" valign="bottom">Base mean</th><th align="left" valign="bottom">Log<sub>2</sub> fold change</th><th align="left" valign="bottom">Adjusted p value</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>H2-K1</italic></td><td align="left" valign="bottom">ENSMUSG00000061232</td><td align="char" char="." valign="bottom">8985.033</td><td align="char" char="." valign="bottom">0.557</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Cst7</italic></td><td align="left" valign="bottom">ENSMUSG00000068129</td><td align="char" char="." valign="bottom">66.028</td><td align="char" char="." valign="bottom">1.634</td><td align="char" char="." valign="bottom">0.010</td></tr><tr><td align="left" valign="bottom"><italic>Cd68</italic></td><td align="left" valign="bottom">ENSMUSG00000018774</td><td align="char" char="." valign="bottom">761.094</td><td align="char" char="." valign="bottom">0.557</td><td align="char" char="." valign="bottom">0.006</td></tr><tr><td align="left" valign="bottom"><italic>Nsg1</italic></td><td align="left" valign="bottom">ENSMUSG00000029126</td><td align="char" char="." valign="bottom">118,453.175</td><td align="char" char="." valign="bottom">−0.214</td><td align="char" char="." valign="bottom">0.041</td></tr><tr><td align="left" valign="bottom"><italic>H2-Q7</italic></td><td align="left" valign="bottom">ENSMUSG00000060550</td><td align="char" char="." valign="bottom">461.700</td><td align="char" char="." valign="bottom">0.761</td><td align="char" char="." valign="bottom">0.001</td></tr><tr><td align="left" valign="bottom"><italic>Nsg2</italic></td><td align="left" valign="bottom">ENSMUSG00000020297</td><td align="char" char="." valign="bottom">17,203.283</td><td align="char" char="." valign="bottom">0.363</td><td align="char" char="." valign="bottom">0.012</td></tr><tr><td align="left" valign="bottom"><italic>Ctsd</italic></td><td align="left" valign="bottom">ENSMUSG00000007891</td><td align="char" char="." valign="bottom">33,856.962</td><td align="char" char="." valign="bottom">0.382</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="char" char="." valign="bottom"><italic>2610002M06Rik</italic></td><td align="left" valign="bottom">ENSMUSG00000031242</td><td align="char" char="." valign="bottom">7455.780</td><td align="char" char="." valign="bottom">−0.157</td><td align="char" char="." valign="bottom">0.038</td></tr><tr><td align="left" valign="bottom"><italic>Prkcd</italic></td><td align="left" valign="bottom">ENSMUSG00000021948</td><td align="char" char="." valign="bottom">15,130.466</td><td align="char" char="." valign="bottom">−0.240</td><td align="char" char="." valign="bottom">0.012</td></tr><tr><td align="left" valign="bottom"><italic>Rab38</italic></td><td align="left" valign="bottom">ENSMUSG00000030559</td><td align="char" char="." valign="bottom">74.954</td><td align="char" char="." valign="bottom">1.387</td><td align="char" char="." valign="bottom">0.042</td></tr><tr><td align="left" valign="bottom"><italic>Ctss</italic></td><td align="left" valign="bottom">ENSMUSG00000038642</td><td align="char" char="." valign="bottom">8398.508</td><td align="char" char="." valign="bottom">0.350</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Tmem25</italic></td><td align="left" valign="bottom">ENSMUSG00000002032</td><td align="char" char="." valign="bottom">16,856.246</td><td align="char" char="." valign="bottom">−0.150</td><td align="char" char="." valign="bottom">0.035</td></tr><tr><td align="left" valign="bottom"><italic>Apoe</italic></td><td align="left" valign="bottom">ENSMUSG00000002985</td><td align="char" char="." valign="bottom">294,918.992</td><td align="char" char="." valign="bottom">0.315</td><td align="char" char="." valign="bottom">0.003</td></tr><tr><td align="left" valign="bottom"><italic>Unc13d</italic></td><td align="left" valign="bottom">ENSMUSG00000057948</td><td align="char" char="." valign="bottom">1948.570</td><td align="char" char="." valign="bottom">−0.298</td><td align="char" char="." valign="bottom">0.025</td></tr><tr><td align="left" valign="bottom"><italic>Cst3</italic></td><td align="left" valign="bottom">ENSMUSG00000027447</td><td align="char" char="." valign="bottom">72,853.485</td><td align="char" char="." valign="bottom">0.250</td><td align="char" char="." valign="bottom">0.046</td></tr><tr><td align="left" valign="bottom"><italic>Arl8a</italic></td><td align="left" valign="bottom">ENSMUSG00000026426</td><td align="char" char="." valign="bottom">23,966.848</td><td align="char" char="." valign="bottom">−0.112</td><td align="char" char="." valign="bottom">0.040</td></tr><tr><td align="left" valign="bottom"><italic>Cd63</italic></td><td align="left" valign="bottom">ENSMUSG00000025351</td><td align="char" char="." valign="bottom">16,922.196</td><td align="char" char="." valign="bottom">0.306</td><td align="char" char="." valign="bottom">0.003</td></tr><tr><td align="left" valign="bottom"><italic>H2-Q4</italic></td><td align="left" valign="bottom">ENSMUSG00000035929</td><td align="char" char="." valign="bottom">1712.362</td><td align="char" char="." valign="bottom">0.637</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>H2-Q6</italic></td><td align="left" valign="bottom">ENSMUSG00000073409</td><td align="char" char="." valign="bottom">605.404</td><td align="char" char="." valign="bottom">0.610</td><td align="char" char="." valign="bottom">0.017</td></tr><tr><td align="left" valign="bottom"><italic>Slc11a1</italic></td><td align="left" valign="bottom">ENSMUSG00000026177</td><td align="char" char="." valign="bottom">351.078</td><td align="char" char="." valign="bottom">0.472</td><td align="char" char="." valign="bottom">0.006</td></tr><tr><td align="left" valign="bottom"><italic>Tinagl1</italic></td><td align="left" valign="bottom">ENSMUSG00000028776</td><td align="char" char="." valign="bottom">1872.544</td><td align="char" char="." valign="bottom">0.444</td><td align="char" char="." valign="bottom">0.013</td></tr><tr><td align="left" valign="bottom"><italic>Gaa</italic></td><td align="left" valign="bottom">ENSMUSG00000025579</td><td align="char" char="." valign="bottom">42,288.649</td><td align="char" char="." valign="bottom">0.148</td><td align="char" char="." valign="bottom">0.046</td></tr><tr><td align="left" valign="bottom"><italic>Npc2</italic></td><td align="left" valign="bottom">ENSMUSG00000021242</td><td align="char" char="." valign="bottom">13,576.144</td><td align="char" char="." valign="bottom">0.252</td><td align="char" char="." valign="bottom">0.005</td></tr><tr><td align="left" valign="bottom"><italic>Cpq</italic></td><td align="left" valign="bottom">ENSMUSG00000039007</td><td align="char" char="." valign="bottom">3671.835</td><td align="char" char="." valign="bottom">0.301</td><td align="char" char="." valign="bottom">0.043</td></tr><tr><td align="left" valign="bottom"><italic>Naga</italic></td><td align="left" valign="bottom">ENSMUSG00000022453</td><td align="char" char="." valign="bottom">5578.299</td><td align="char" char="." valign="bottom">0.171</td><td align="char" char="." valign="bottom">0.009</td></tr><tr><td align="left" valign="bottom"><italic>Man2b2</italic></td><td align="left" valign="bottom">ENSMUSG00000029119</td><td align="char" char="." valign="bottom">5625.125</td><td align="char" char="." valign="bottom">0.227</td><td align="char" char="." valign="bottom">0.008</td></tr><tr><td align="left" valign="bottom"><italic>Gfap</italic></td><td align="left" valign="bottom">ENSMUSG00000020932</td><td align="char" char="." valign="bottom">49,633.449</td><td align="char" char="." valign="bottom">0.670</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Hexb</italic></td><td align="left" valign="bottom">ENSMUSG00000021665</td><td align="char" char="." valign="bottom">11,580.391</td><td align="char" char="." valign="bottom">0.325</td><td align="char" char="." valign="bottom">0.001</td></tr><tr><td align="left" valign="bottom"><italic>Lipa</italic></td><td align="left" valign="bottom">ENSMUSG00000024781</td><td align="char" char="." valign="bottom">3011.385</td><td align="char" char="." valign="bottom">0.339</td><td align="char" char="." valign="bottom">0.003</td></tr><tr><td align="left" valign="bottom"><italic>Meak7</italic></td><td align="left" valign="bottom">ENSMUSG00000034105</td><td align="char" char="." valign="bottom">1681.762</td><td align="char" char="." valign="bottom">0.255</td><td align="char" char="." valign="bottom">0.012</td></tr><tr><td align="left" valign="bottom"><italic>Ifi30</italic></td><td align="left" valign="bottom">ENSMUSG00000031838</td><td align="char" char="." valign="bottom">755.863</td><td align="char" char="." valign="bottom">0.547</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Trip10</italic></td><td align="left" valign="bottom">ENSMUSG00000019487</td><td align="char" char="." valign="bottom">1776.641</td><td align="char" char="." valign="bottom">0.312</td><td align="char" char="." valign="bottom">0.029</td></tr><tr><td align="left" valign="bottom"><italic>Borcs8</italic></td><td align="left" valign="bottom">ENSMUSG00000002345</td><td align="char" char="." valign="bottom">2644.624</td><td align="char" char="." valign="bottom">−0.392</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Myo7a</italic></td><td align="left" valign="bottom">ENSMUSG00000030761</td><td align="char" char="." valign="bottom">5484.873</td><td align="char" char="." valign="bottom">0.552</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Syt7</italic></td><td align="left" valign="bottom">ENSMUSG00000024743</td><td align="char" char="." valign="bottom">66,668.649</td><td align="char" char="." valign="bottom">−0.232</td><td align="char" char="." valign="bottom">0.001</td></tr><tr><td align="left" valign="bottom"><italic>Gusb</italic></td><td align="left" valign="bottom">ENSMUSG00000025534</td><td align="char" char="." valign="bottom">2558.973</td><td align="char" char="." valign="bottom">0.185</td><td align="char" char="." valign="bottom">0.017</td></tr><tr><td align="left" valign="bottom"><italic>Rnf19b</italic></td><td align="left" valign="bottom">ENSMUSG00000028793</td><td align="char" char="." valign="bottom">28,209.761</td><td align="char" char="." valign="bottom">−0.243</td><td align="char" char="." valign="bottom">0.038</td></tr><tr><td align="left" valign="bottom"><italic>Ctsc</italic></td><td align="left" valign="bottom">ENSMUSG00000030560</td><td align="char" char="." valign="bottom">1554.587</td><td align="char" char="." valign="bottom">0.610</td><td align="char" char="." valign="bottom">0.003</td></tr><tr><td align="left" valign="bottom"><italic>Laptm5</italic></td><td align="left" valign="bottom">ENSMUSG00000028581</td><td align="char" char="." valign="bottom">2659.155</td><td align="char" char="." valign="bottom">0.278</td><td align="char" char="." valign="bottom">0.006</td></tr><tr><td align="left" valign="bottom"><italic>Acp5</italic></td><td align="left" valign="bottom">ENSMUSG00000001348</td><td align="char" char="." valign="bottom">57.183</td><td align="char" char="." valign="bottom">1.434</td><td align="char" char="." valign="bottom">0.004</td></tr><tr><td align="left" valign="bottom"><italic>Inpp5f</italic></td><td align="left" valign="bottom">ENSMUSG00000042105</td><td align="char" char="." valign="bottom">25,096.641</td><td align="char" char="." valign="bottom">−0.158</td><td align="char" char="." valign="bottom">0.005</td></tr><tr><td align="left" valign="bottom"><italic>Rusc1</italic></td><td align="left" valign="bottom">ENSMUSG00000041263</td><td align="char" char="." valign="bottom">8435.506</td><td align="char" char="." valign="bottom">−0.146</td><td align="char" char="." valign="bottom">0.044</td></tr><tr><td align="left" valign="bottom"><italic>Pld1</italic></td><td align="left" valign="bottom">ENSMUSG00000027695</td><td align="char" char="." valign="bottom">1492.635</td><td align="char" char="." valign="bottom">0.305</td><td align="char" char="." valign="bottom">0.013</td></tr><tr><td align="left" valign="bottom"><italic>Ticam2</italic></td><td align="left" valign="bottom">ENSMUSG00000056130</td><td align="char" char="." valign="bottom">58.459</td><td align="char" char="." valign="bottom">1.110</td><td align="char" char="." valign="bottom">0.010</td></tr><tr><td align="left" valign="bottom"><italic>Rassf9</italic></td><td align="left" valign="bottom">ENSMUSG00000044921</td><td align="char" char="." valign="bottom">702.197</td><td align="char" char="." valign="bottom">0.316</td><td align="char" char="." valign="bottom">0.017</td></tr><tr><td align="left" valign="bottom"><italic>Mr1</italic></td><td align="left" valign="bottom">ENSMUSG00000026471</td><td align="char" char="." valign="bottom">1753.049</td><td align="char" char="." valign="bottom">0.342</td><td align="char" char="." valign="bottom">0.006</td></tr><tr><td align="left" valign="bottom"><italic>Ece1</italic></td><td align="left" valign="bottom">ENSMUSG00000057530</td><td align="char" char="." valign="bottom">21,877.619</td><td align="char" char="." valign="bottom">−0.213</td><td align="char" char="." valign="bottom">0.007</td></tr><tr><td align="left" valign="bottom"><italic>Sh3gl3</italic></td><td align="left" valign="bottom">ENSMUSG00000030638</td><td align="char" char="." valign="bottom">1097.889</td><td align="char" char="." valign="bottom">0.255</td><td align="char" char="." valign="bottom">0.046</td></tr><tr><td align="left" valign="bottom"><italic>Ptprf</italic></td><td align="left" valign="bottom">ENSMUSG00000033295</td><td align="char" char="." valign="bottom">6447.473</td><td align="char" char="." valign="bottom">0.311</td><td align="char" char="." valign="bottom">0.032</td></tr><tr><td align="left" valign="bottom"><italic>Washc2</italic></td><td align="left" valign="bottom">ENSMUSG00000024104</td><td align="char" char="." valign="bottom">71,355.731</td><td align="char" char="." valign="bottom">−0.263</td><td align="char" char="." valign="bottom">0.033</td></tr><tr><td align="left" valign="bottom"><italic>Syndig1</italic></td><td align="left" valign="bottom">ENSMUSG00000074736</td><td align="char" char="." valign="bottom">15,931.471</td><td align="char" char="." valign="bottom">−0.199</td><td align="char" char="." valign="bottom">0.019</td></tr><tr><td align="left" valign="bottom"><italic>Pld4</italic></td><td align="left" valign="bottom">ENSMUSG00000052160</td><td align="char" char="." valign="bottom">865.562</td><td align="char" char="." valign="bottom">0.329</td><td align="char" char="." valign="bottom">0.046</td></tr><tr><td align="left" valign="bottom"><italic>Ackr4</italic></td><td align="left" valign="bottom">ENSMUSG00000079355</td><td align="char" char="." valign="bottom">668.906</td><td align="char" char="." valign="bottom">0.813</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Unc93b1</italic></td><td align="left" valign="bottom">ENSMUSG00000036908</td><td align="char" char="." valign="bottom">1732.922</td><td align="char" char="." valign="bottom">0.268</td><td align="char" char="." valign="bottom">0.014</td></tr><tr><td align="left" valign="bottom"><italic>Rab11a</italic></td><td align="left" valign="bottom">ENSMUSG00000004771</td><td align="char" char="." valign="bottom">12,908.215</td><td align="char" char="." valign="bottom">−0.146</td><td align="char" char="." valign="bottom">0.028</td></tr><tr><td align="left" valign="bottom"><italic>Rnd2</italic></td><td align="left" valign="bottom">ENSMUSG00000001313</td><td align="char" char="." valign="bottom">14,349.243</td><td align="char" char="." valign="bottom">0.181</td><td align="char" char="." valign="bottom">0.030</td></tr><tr><td align="left" valign="bottom"><italic>H2-Ab1</italic></td><td align="left" valign="bottom">ENSMUSG00000073421</td><td align="char" char="." valign="bottom">394.199</td><td align="char" char="." valign="bottom">0.802</td><td align="char" char="." valign="bottom">0.005</td></tr><tr><td align="left" valign="bottom"><italic>Pacsin1</italic></td><td align="left" valign="bottom">ENSMUSG00000040276</td><td align="char" char="." valign="bottom">65,047.878</td><td align="char" char="." valign="bottom">−0.166</td><td align="char" char="." valign="bottom">0.017</td></tr><tr><td align="left" valign="bottom"><italic>Ackr3</italic></td><td align="left" valign="bottom">ENSMUSG00000044337</td><td align="char" char="." valign="bottom">1329.920</td><td align="char" char="." valign="bottom">0.292</td><td align="char" char="." valign="bottom">0.032</td></tr><tr><td align="left" valign="bottom"><italic>Snap25</italic></td><td align="left" valign="bottom">ENSMUSG00000027273</td><td align="char" char="." valign="bottom">334,660.707</td><td align="char" char="." valign="bottom">−0.225</td><td align="char" char="." valign="bottom">0.005</td></tr><tr><td align="left" valign="bottom"><italic>Map2k1</italic></td><td align="left" valign="bottom">ENSMUSG00000004936</td><td align="char" char="." valign="bottom">25,321.319</td><td align="char" char="." valign="bottom">−0.117</td><td align="char" char="." valign="bottom">0.046</td></tr><tr><td align="left" valign="bottom"><italic>Cd22</italic></td><td align="left" valign="bottom">ENSMUSG00000030577</td><td align="char" char="." valign="bottom">81.223</td><td align="char" char="." valign="bottom">0.856</td><td align="char" char="." valign="bottom">0.003</td></tr><tr><td align="left" valign="bottom"><italic>Nrp1</italic></td><td align="left" valign="bottom">ENSMUSG00000025810</td><td align="char" char="." valign="bottom">1247.448</td><td align="char" char="." valign="bottom">0.283</td><td align="char" char="." valign="bottom">0.042</td></tr><tr><td align="left" valign="bottom"><italic>Kcnj11</italic></td><td align="left" valign="bottom">ENSMUSG00000096146</td><td align="char" char="." valign="bottom">7056.627</td><td align="char" char="." valign="bottom">−0.188</td><td align="char" char="." valign="bottom">0.025</td></tr><tr><td align="left" valign="bottom"><italic>Fcgrt</italic></td><td align="left" valign="bottom">ENSMUSG00000003420</td><td align="char" char="." valign="bottom">4913.386</td><td align="char" char="." valign="bottom">0.239</td><td align="char" char="." valign="bottom">0.013</td></tr><tr><td align="left" valign="bottom"><italic>Dgkh</italic></td><td align="left" valign="bottom">ENSMUSG00000034731</td><td align="char" char="." valign="bottom">13,465.118</td><td align="char" char="." valign="bottom">−0.264</td><td align="char" char="." valign="bottom">0.022</td></tr><tr><td align="left" valign="bottom"><italic>Bsg</italic></td><td align="left" valign="bottom">ENSMUSG00000023175</td><td align="char" char="." valign="bottom">98,426.046</td><td align="char" char="." valign="bottom">0.221</td><td align="char" char="." valign="bottom">0.048</td></tr><tr><td align="left" valign="bottom"><italic>Rnf128</italic></td><td align="left" valign="bottom">ENSMUSG00000031438</td><td align="char" char="." valign="bottom">4114.551</td><td align="char" char="." valign="bottom">−0.181</td><td align="char" char="." valign="bottom">0.016</td></tr><tr><td align="left" valign="bottom"><italic>Stambpl1</italic></td><td align="left" valign="bottom">ENSMUSG00000024776</td><td align="char" char="." valign="bottom">2576.502</td><td align="char" char="." valign="bottom">−0.196</td><td align="char" char="." valign="bottom">0.023</td></tr><tr><td align="left" valign="bottom"><italic>Cpne6</italic></td><td align="left" valign="bottom">ENSMUSG00000022212</td><td align="char" char="." valign="bottom">2074.575</td><td align="char" char="." valign="bottom">0.537</td><td align="char" char="." valign="bottom">0.003</td></tr><tr><td align="left" valign="bottom"><italic>Ccr5</italic></td><td align="left" valign="bottom">ENSMUSG00000079227</td><td align="char" char="." valign="bottom">417.390</td><td align="char" char="." valign="bottom">0.454</td><td align="char" char="." valign="bottom">0.030</td></tr><tr><td align="left" valign="bottom"><italic>Dagla</italic></td><td align="left" valign="bottom">ENSMUSG00000035735</td><td align="char" char="." valign="bottom">19,804.120</td><td align="char" char="." valign="bottom">−0.336</td><td align="char" char="." valign="bottom">0.012</td></tr><tr><td align="left" valign="bottom"><italic>Zfyve21</italic></td><td align="left" valign="bottom">ENSMUSG00000021286</td><td align="char" char="." valign="bottom">2110.324</td><td align="char" char="." valign="bottom">0.191</td><td align="char" char="." valign="bottom">0.021</td></tr><tr><td align="left" valign="bottom"><italic>Dner</italic></td><td align="left" valign="bottom">ENSMUSG00000036766</td><td align="char" char="." valign="bottom">118,667.368</td><td align="char" char="." valign="bottom">−0.372</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Grb14</italic></td><td align="left" valign="bottom">ENSMUSG00000026888</td><td align="char" char="." valign="bottom">2737.028</td><td align="char" char="." valign="bottom">0.223</td><td align="char" char="." valign="bottom">0.030</td></tr><tr><td align="left" valign="bottom"><italic>Scoc</italic></td><td align="left" valign="bottom">ENSMUSG00000063253</td><td align="char" char="." valign="bottom">12,593.242</td><td align="char" char="." valign="bottom">−0.778</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Mrc1</italic></td><td align="left" valign="bottom">ENSMUSG00000026712</td><td align="char" char="." valign="bottom">489.484</td><td align="char" char="." valign="bottom">0.466</td><td align="char" char="." valign="bottom">0.045</td></tr><tr><td align="left" valign="bottom"><italic>Epn3</italic></td><td align="left" valign="bottom">ENSMUSG00000010080</td><td align="char" char="." valign="bottom">4581.906</td><td align="char" char="." valign="bottom">0.446</td><td align="char" char="." valign="bottom">0.009</td></tr><tr><td align="left" valign="bottom"><italic>Gfra1</italic></td><td align="left" valign="bottom">ENSMUSG00000025089</td><td align="char" char="." valign="bottom">1244.452</td><td align="char" char="." valign="bottom">0.557</td><td align="char" char="." valign="bottom">0.006</td></tr><tr><td align="left" valign="bottom"><italic>Tpd52l1</italic></td><td align="left" valign="bottom">ENSMUSG00000000296</td><td align="char" char="." valign="bottom">1312.485</td><td align="char" char="." valign="bottom">0.471</td><td align="char" char="." valign="bottom">0.033</td></tr><tr><td align="left" valign="bottom"><italic>Vcam1</italic></td><td align="left" valign="bottom">ENSMUSG00000027962</td><td align="char" char="." valign="bottom">3713.941</td><td align="char" char="." valign="bottom">0.429</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom"><italic>Spns2</italic></td><td align="left" valign="bottom">ENSMUSG00000040447</td><td align="char" char="." valign="bottom">9562.590</td><td align="char" char="." valign="bottom">−0.159</td><td align="char" char="." valign="bottom">0.029</td></tr></tbody></table></table-wrap><sec id="s2-1"><title>Early endosomes are enlarged and accumulate BDNF and TrkB in Purkinje cells in SCA6 mice</title><p>Early endosomes are the first stop for newly endocytosed cargo. There, cargo undergoes sorting as the slightly acidic pH facilitates ligand release from receptors (<xref ref-type="fig" rid="fig2">Figure 2a</xref>). We carried out immunohistochemistry (IHC) against early endosome antigen 1 (EEA1) on sections of cerebellar vermis from 7- to 8-month WT and SCA6 mice and found that EEA1 staining is present in the cerebellum, particularly in Purkinje cells (<xref ref-type="fig" rid="fig2">Figure 2b</xref>). We imaged Purkinje cells and could identify large tubular early endosomes in Purkinje cell somas of both WT and SCA6 mice (<xref ref-type="fig" rid="fig2">Figure 2b, c</xref>). The early endosome marker in SCA6 Purkinje cells covered a larger area, showing that the early endosome compartment is enlarged in SCA6 (<xref ref-type="fig" rid="fig2">Figure 2c,d</xref>). A similar enlargement of early endosomes has been seen in other neurological diseases (<xref ref-type="bibr" rid="bib8">Cataldo et al., 2000</xref>; <xref ref-type="bibr" rid="bib7">Cataldo et al., 1997</xref>; <xref ref-type="bibr" rid="bib30">Jin et al., 2004</xref>). Using the EEA1 marker to delineate early endosomes, we were able to analyze BDNF and TrkB localized within the early endosome compartment. There was a higher amount of BDNF staining within the early endosomes of Purkinje cells from SCA6 mice (<xref ref-type="fig" rid="fig2">Figure 2e, f</xref>). This was intriguing as we have previously shown that BDNF levels in the cerebellar vermis as a whole are decreased (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>), so BDNF accumulates specifically in this compartment despite depressed levels overall in the cerebellum. We found the same was true for TrkB, as TrkB immunoreactivity was increased within the EEA1-positive early endosome compartment in SCA6 Purkinje cells compared to WT (<xref ref-type="fig" rid="fig2">Figure 2g, h</xref>). Nearly all of the TrkB staining within SCA6 Purkinje cells colocalized with the EEA1 marker (<xref ref-type="fig" rid="fig2">Figure 2g</xref>, arrowheads), whereas the tissue from WT mice showed abundant TrkB staining outside the early endosome compartment of Purkinje cells (<xref ref-type="fig" rid="fig2">Figure 2g</xref>, arrowheads). Thus, early endosomes are enlarged and accumulate BDNF and TrkB in SCA6, despite decreased levels of both proteins in the SCA6 cerebellum as a whole. This cargo mis-trafficking could lead to a decrease in the amount of free BDNF available to signal, as well as the amount of TrkB recycled to the cell surface, thereby contributing to previously described BDNF–TrkB signaling deficits in SCA6 (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Early endosomes are enlarged and accumulate brain-derived neurotrophic factor (BDNF) and tropomyosin kinase B (TrkB) in spinocerebellar ataxia type 6 (SCA6) Purkinje cells.</title><p>(<bold>a</bold>) Schematic showing BDNF and TrkB endocytosis and trafficking to early endosomes labeled with early endosome antigen 1 (EEA1). (<bold>b</bold>) The early endosome marker EEA1 stains early endosomes in lobule 3 of the cerebellar vermis in wildtype (WT) and SCA6 mice, calbindin labels Purkinje cells. Scale bar, 100 µm. (<bold>c</bold>) Closeup images of the early endosome marker EEA1 in lobule 3 of cerebellum, calbindin labels Purkinje cells (outlined). Scale bar, 10 µm. (<bold>d</bold>) The area covered by EEA1 staining in Purkinje cells is increased in SCA6 mice compared to WT (p &lt; 0.001; <italic>N</italic> = 6 WT mice, 173 cells; 5 SCA6 mice, 171 cells). (<bold>e</bold>) Representative images of the early endosome marker EEA1 and BDNF within Purkinje cells (outlined) in the anterior vermis. Scale bar, 10 µm. (<bold>f</bold>) Relative staining level of BDNF within early endosome compartment is higher in the Purkinje cells of SCA6 mice compared to WT (p &lt; 0.001; <italic>N</italic> = 6 WT mice, 173 cells; 5 SCA6 mice, 171 cells). (<bold>g</bold>) Representative images of the early endosome marker EEA1 and TrkB within Purkinje cells (outlined) in the anterior vermis. Arrowheads denote locations of significant TrkB accumulations. Scale bar, 10 µm. (<bold>h</bold>) Relative staining level of TrkB within early endosome compartment is higher in the Purkinje cells of SCA6 mice compared to WT (p = 0.013; <italic>N</italic> = 4 WT mice, 79 cells; 4 SCA6 mice, 58 cells). Mann–Whitney <italic>U</italic>-test used for all statistical comparisons, *p &lt; 0.05, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig2-v1.tif"/></fig></sec><sec id="s2-2"><title>Recycling endosomes are morphologically normal in SCA6</title><p>Since we identified an accumulation of TrkB in early endosomes, we wondered whether this would affect the amount of TrkB recycled back to the cell surface. Recycling endosomes return receptors to the plasma membrane for further signaling (<xref ref-type="fig" rid="fig3">Figure 3a</xref>; <xref ref-type="bibr" rid="bib48">O’Sullivan and Lindsay, 2020</xref>). Syntaxin 12/13 (Stx13) is involved in recycling of endocytosed proteins back to the plasma membrane and is located in recycling endosomes and some tubular protrusions from early endosomes that are also involved in recycling (<xref ref-type="bibr" rid="bib52">Prekeris et al., 1998</xref>). We used two different antibodies for Stx13 as a marker for the recycling endosome compartment. Staining with both antibodies revealed a large network of small recycling endosomes and protrusions in Purkinje cells (<xref ref-type="fig" rid="fig3">Figure 3b</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Analysis of the staining with both antibodies showed that recycling endosome area was unchanged in SCA6 Purkinje cells (<xref ref-type="fig" rid="fig3">Figure 3c</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We noted colocalization between TrkB and Stx13, showing TrkB being recycled back to the cell surface after dissociation from bound BDNF in the early endosomes. The TrkB staining within the recycling endosome compartment marked by Stx13 was decreased in Purkinje cells in SCA6 mice (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). Combined with the increased levels of TrkB in the early endosomes of Purkinje cells in SCA6 (<xref ref-type="fig" rid="fig2">Figure 2h</xref>), these data argue that TrkB is stuck in early endosomes in SCA6, rather than being recycled to the cell surface to the same extent as in WT Purkinje cells. This mislocalization may contribute to the depressed levels of BDNF–TrkB signaling previously described in SCA6 (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Recycling of tropomyosin kinase B (TrkB) in recycling endosomes is impaired in spinocerebellar ataxia type 6 (SCA6) Purkinje cells.</title><p>(<bold>a</bold>) Schematic showing the return of TrkB to the cell membrane via recycling endosomes labeled with Stx13. (<bold>b</bold>) Representative images of the recycling endosome marker Stx13 and TrkB within Purkinje cells (outlined) of the anterior vermis. Scale bar, 10 µm. (<bold>c</bold>) The area covered by Stx13 staining in Purkinje cells is unchanged between wildtype (WT) and SCA6 mice (p = 0.96; <italic>N</italic> = 4 WT mice, 67 cells; 4 SCA6 mice, 66 cells). (<bold>d</bold>) The relative level of TrkB within recycling endosomes was significantly decreased in SCA6 Purkinje cells (p = 0.0034; <italic>N</italic> = 4 WT mice, 67 cells; 4 SCA6 mice, 66 cells). Mann–Whitney <italic>U</italic>-test used for all statistical comparisons, **p &lt; 0.01, n.s. p &gt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>A second Stx13 antibody confirms that recycling endosome area is unchanged in spinocerebellar ataxia type 6 (SCA6) Purkinje cells.</title><p>(<bold>a</bold>) Representative image of the recycling endosome marker Stx13 within Purkinje cells of the anterior vermis. Scale bar, 10 µm. (<bold>b</bold>) The area covered by Stx13 staining in Purkinje cells is unchanged between wildtype (WT) and SCA6 mice (p = 0.59; Mann–Whitney <italic>U</italic>-test; <italic>N</italic> = 4 WT mice, 268 cells; 6 SCA6 mice, 304 cells). n.s. p &gt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Late endosomes</title><p>Early endosomes undergo maturation into late endosomes in order to transport cargo destined for degradation to the lysosomes (<xref ref-type="bibr" rid="bib27">Huotari and Helenius, 2011</xref>; <xref ref-type="fig" rid="fig4">Figure 4a</xref>). Neurons use this degradative pathway as a way to regulate BDNF levels (<xref ref-type="bibr" rid="bib22">Evans et al., 2011</xref>). We used Rab7 as a marker for late endosomes (<xref ref-type="bibr" rid="bib66">Vitelli et al., 1997</xref>), and identified numerous late endosomes in Purkinje cells of both WT and SCA6 mice (<xref ref-type="fig" rid="fig4">Figure 4b</xref>). The Rab7 staining covered a smaller area in the Purkinje cells of SCA6 mice compared to WT (<xref ref-type="fig" rid="fig4">Figure 4c</xref>), indicating a reduction in the size or number of late endosomes. Most of the BDNF staining within the Purkinje cells did not colocalize with Rab7 (<xref ref-type="fig" rid="fig4">Figure 4b</xref>), which was expected as we had previously found high levels of colocalization of BDNF with the early endosome marker EEA1 (<xref ref-type="fig" rid="fig2">Figure 2e</xref>). The BDNF staining that was present within the Rab7-positive late endosome compartment was significantly reduced in SCA6 compared to WT (<xref ref-type="fig" rid="fig4">Figure 4d</xref>), suggesting that BDNF accumulates in the early endosomes earlier in the endosomal pathway (<xref ref-type="fig" rid="fig2">Figure 2f</xref>), preventing its progression through the late endosomal stage. Late endosomes transport cargo to lysosomes for degradation, so less BDNF may reach the lysosome in SCA6. This could have implications for the regulation of BDNF within Purkinje cells, as neurons tightly regulate BDNF levels via degradative pathways (<xref ref-type="bibr" rid="bib22">Evans et al., 2011</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Late endosomes are reduced in spinocerebellar ataxia type 6 (SCA6) Purkinje cells and carry less brain-derived neurotrophic factor (BDNF).</title><p>(<bold>a</bold>) Schematic showing the transport of BDNF in late endosomes expressing Rab7. (<bold>b</bold>) Representative images of the late endosome marker Rab7 and BDNF within Purkinje cells (outlined) of the anterior vermis. Scale bar, 10 µm. (<bold>c</bold>) The area covered by Rab7 staining in Purkinje cells is decreased in SCA6 mice compared to wildtype (WT) (p = 0.0019; <italic>N</italic> = 4 WT mice, 93 cells; 4 SCA6 mice, 81 cells). (<bold>d</bold>) The relative level of BDNF within late endosomes was significantly decreased in SCA6 Purkinje cells (p &lt; 0.001; <italic>N</italic> = 4 WT mice, 93 cells; 4 SCA6 mice, 81 cells). Mann–Whitney <italic>U</italic>-test used for all statistical comparisons, **p &lt; 0.01, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig4-v1.tif"/></fig></sec><sec id="s2-4"><title>Lysosomal morphology is unchanged in SCA6</title><p>We next aimed to determine whether lysosomes were altered in SCA6, using a dual strategy to visualize the lysosomes in cerebellar slices. We first used a pH-sensitive dye, LysoTracker Red DND 99, to visualize the acidic lysosomes (<xref ref-type="fig" rid="fig5">Figure 5a, b</xref>; <xref ref-type="bibr" rid="bib12">Chazotte, 2011</xref>). As LysoTracker labels all acidic compartments, it is not sufficient to confirm the identity of lysosomes. This may be particularly problematic if other intracellular compartments undergo inappropriate acidification, which has been observed in other neurological diseases (<xref ref-type="bibr" rid="bib51">Pescosolido et al., 2021</xref>). Therefore, after staining acute cerebellar slices with LysoTracker, we performed IHC for Lysosomal-associated membrane protein 1 (Lamp1), a glycoprotein localized at the membranes of lysosomes. Because even Lamp1 can be localized outside of lysosomes (<xref ref-type="bibr" rid="bib16">Cheng et al., 2018</xref>), we used both LysoTracker and Lamp1 to identify lysosomes in Purkinje cells. We found that both stains labelled lysosomes within Purkinje cells (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). As expected, the Lamp1 staining appeared as ring-like structures, marking the membranes of the lysosomes, while LysoTracker staining marked the acidic lumen of the lysosomes, in the center of these rings (<xref ref-type="fig" rid="fig5">Figure 5b</xref>, see zoom). While Lamp1 staining identified a large number of lysosomes of varying size, the LysoTracker stain was present only in the largest. This discrepancy has been noted previously, as LysoTracker does not label the smallest lysosomes in cerebellar slices or other cell preparations that are fixed after staining (<xref ref-type="bibr" rid="bib12">Chazotte, 2011</xref>; <xref ref-type="bibr" rid="bib59">Song et al., 2008</xref>). We found that the total area covered by the Lamp1 and LysoTracker stains was not significantly different between Purkinje cells from WT and SCA6 mice (<xref ref-type="fig" rid="fig5">Figure 5c, d</xref>). The area of colocalization between the two stains was also unchanged (<xref ref-type="fig" rid="fig5">Figure 5e</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Lysosomes in spinocerebellar ataxia type 6 (SCA6) Purkinje cells are morphologically normal but there may be a deficit in late endosome maturation.</title><p>(<bold>a</bold>) Schematic showing the endo-lysosomal system as a series of compartments of increasingly acidic pH with lysosomes, expressing Lamp1, being most acidic. (<bold>b</bold>) Representative images of Purkinje cells in the anterior vermis stained for the lysosome membrane marker Lamp1 and LysoTracker as a marker of acidic compartments. Calbindin labels Purkinje cells (outlined). Scale bar, 10 µm. The area covered by (<bold>c</bold>) Lamp1 staining and (<bold>d</bold>) LysoTracker staining in Purkinje cells is unchanged between wildtype (WT) and SCA6 mice (p = 0.26 for Lamp1; p = 0.20 for LysoTracker; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 76 cells). (<bold>e</bold>) The area of colocalization between Lamp1 and Lysotracker is unchanged between WT and SCA6 mice (p = 0.34; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 76 cells). (<bold>f</bold>) The number of lysosomes that were both Lamp1- and LysoTracker positive was not significantly different between genotypes (p = 0.72; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 76 cells). (<bold>g</bold>) The number of lysosomes that were Lamp1 positive, but LysoTracker negative was unchanged between genotypes (p = 0.83; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 76 cells). (<bold>h</bold>) The number of putative late endosomes undergoing maturation that were Lamp1 negative, but LysoTracker positive was significantly decreased in the Purkinje cells of SCA6 mice (p = 0.034; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 76 cells). Mann–Whitney <italic>U</italic>-test used for all statistical comparisons except number of Lamp1+ puncta (<bold>f</bold>) which was normally distributed and so a Student’s <italic>t</italic>-test was used, *p &lt; 0.05, n.s. p &gt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Lysosome size is unchanged in spinocerebellar ataxia type 6 (SCA6) Purkinje cells.</title><p>(<bold>a</bold>) The area covered by Lamp1 staining divided by the number of Lamp1-positive organelles is not significantly different in the Purkinje cells of wildtype (WT) and SCA6 mice (p = 0.093; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 76 cells). (<bold>b</bold>) The area covered by LysoTracker staining divided by the number of LysoTracker-positive organelles is not significantly different in the Purkinje cells of WT and SCA6 mice (p = 0.14; <italic>N</italic> = 3 WT mice, 3 SCA6 mice). Mann–Whitney <italic>U</italic>-test used for all statistical comparisons; n.s. p &gt; 0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig5-figsupp1-v1.tif"/></fig></fig-group><p>To investigate further and determine whether the two stains label the same population of lysosomes in the two genotypes, we counted the number of lysosomes labeled by different combinations of the two markers. The lysosomes labeled by these two strategies could be divided into three groups. (1) Compartments stained by both Lamp1 and LysoTracker, confirming that they are indeed lysosomes. The number of these lysosomes was indistinguishable between WT and SCA6 mice (<xref ref-type="fig" rid="fig5">Figure 5f</xref>), indicating that Lamp1-positive lysosomes are present in normal quantities and are appropriately acidified in SCA6 Purkinje cells. In agreement, the area covered by each stain per lysosome, a proxy for the size of the lysosomes, was unchanged in SCA6 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). (2) Lysosomes labeled by Lamp1 but not LysoTracker (<xref ref-type="fig" rid="fig5">Figure 5g</xref>) represent small lysosomes unable to retain the LysoTracker dye after fixation (<xref ref-type="bibr" rid="bib12">Chazotte, 2011</xref>; <xref ref-type="bibr" rid="bib59">Song et al., 2008</xref>). This number was not significantly different between WT and SCA6 mice and so Lamp1 appears to be present at normal levels and is appropriately localized to lysosomes in SCA6. (3) Organelles labeled by LysoTracker but not Lamp1 could include maturing late endosomes or other endosomal compartments that are inappropriately acidified. Late endosomes have an acidic pH and Rab7-positive late endosomes can be LysoTracker positive (<xref ref-type="bibr" rid="bib43">Majzoub et al., 2016</xref>). Late endosomes fuse with lysosomes to complete cargo degradation, but first they mature into an intermediate compartment called an endolysosome (<xref ref-type="bibr" rid="bib27">Huotari and Helenius, 2011</xref>). Therefore, these LysoTracker-positive Lamp1-negative organelles could be late endosomes or intermediate endolysosomes that have not yet fused with the Lamp1-positive lysosomes. The number of these compartments was low in Purkinje cells in both genotypes but was significantly lower in SCA6 mice (<xref ref-type="fig" rid="fig5">Figure 5h</xref>). This agrees with our finding of a reduction in the size of the late endosome compartment in SCA6 mice (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). A reduction in the late endosome compartment suggests that there are fewer late endosomes available to mature and fuse with lysosomes. Therefore, the Lamp1-positive lysosomes are morphologically normal in the Purkinje cells of SCA6 mice while the small alteration in Lysotracker staining likely represents a deficit in the maturation of late endosomes before fusion with lysosomes.</p><p>Taken together, these results suggest that although lysosomes are present in normal numbers, the trafficking of endocytosed cargo to the lysosome for degradation is impaired in the SCA6 cerebellum. Our transcriptomic data furthermore show that genes encoding lysosomal proteins are abnormally expressed in SCA6 (<xref ref-type="fig" rid="fig1">Figure 1b</xref>), suggesting that lysosomal dysfunction is present in SCA6. Lysosomes are enzymatically active sites of degradation and contain multiple proteases that rapidly break down proteins. However, lysosomal proteolysis depends not just on enzymatic activity, but on the correct transport of proteins to the lysosomes through endosomal compartments. We wondered whether the deficits we identified in early and late endosomes (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig4">4</xref>), or other deficits in lysosome activity, might impair the ability of lysosomes to degrade endocytosed cargo in SCA6. We assayed this by incubating acute cerebellar slices with BODIPY FL Pepstatin A, an exogenous peptide that can be endocytosed and transported to the lysosome, where it binds to the active form of the lysosomal enzyme Cathepsin D (<xref ref-type="bibr" rid="bib13">Chen et al., 2000</xref>; <xref ref-type="fig" rid="fig6">Figure 6a</xref>). We could visualize Pepstatin A signal within Lamp1-positive puncta, demonstrating Cathepsin D enzymatic activity within lysosomes (<xref ref-type="fig" rid="fig6">Figure 6b</xref>). The Pepstatin A signal within Purkinje cells was significantly reduced in SCA6 mice (<xref ref-type="fig" rid="fig6">Figure 6c, d</xref>), revealing a lower level of either the endocytosed construct, or of active Cathepsin D. The identification of alterations in the early and late endosomes that transport cargo to the lysosomes (<xref ref-type="fig" rid="fig2">Figures 2</xref> and <xref ref-type="fig" rid="fig4">4</xref>), suggests that SCA6 Purkinje cells have endosomal deficits that reduce transport of the endocytosed Pepstatin A construct to the lysosome where it can bind active Cathepsin D. This finding is therefore consistent with an overall impairment of endo-lysosomal trafficking. The reduction in Pepstatin A signal would also be consistent with a reduction in Cathepsin D enzymatic activity that could further contribute to aberrant handling of endocytosed cargo in SCA6. RNA-sequencing identified an upregulation of lysosomal enzyme transcripts in the SCA6 cerebellum, including the <italic>CTSD</italic> gene encoding Cathepsin D (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). However, this would not necessarily lead to an increase in enzyme activity as the RNA must first be translated, and then undergo post-translational proteolytic processing in order to produce the active form of Cathepsin D that binds Pepstatin A (<xref ref-type="bibr" rid="bib70">Zaidi et al., 2008</xref>). This suggests that in SCA6, there is an upregulation in <italic>CTSD</italic> and other lysosomal genes that does not lead to an increase in functional enzymes. This may be a compensatory mechanism for trafficking deficits of cargoes to the lysosomal compartment, or an attempt to compensate for deficits in the production of the active form of Cathepsin D. In summary, our results illustrate that Purkinje cells in SCA6 mice have an impaired ability to degrade other endocytosed cargo beyond BDNF and TrkB. This likely arises from trafficking deficits that result in a disruption in the transport of cargo to the lysosomes, along with lysosomal dysfunction.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Trafficking of an exogenous peptide to the lysosome shows impairment in lysosomal action on endocytosed cargo in spinocerebellar ataxia type 6 (SCA6).</title><p>(<bold>a</bold>) Schematic showing the use of Pepstatin A BODIPY FL construct to visualize endosome trafficking and Cathepsin D activity. (<bold>b</bold>) Representative images of Pepstatin A staining in the anterior vermis. Top row shows colocalization with lysosome marker Lamp1, Calbindin labels Purkinje cells (outlined). Scale bars, 10 µm (<bold>c</bold>) The area covered by Pepstatin A staining in Purkinje cells was significantly decreased in SCA6 mice (p = 0.00076; <italic>N</italic> = 3 wildtype (WT) mice, 78 cells; 3 SCA6 mice, 66 cells). (<bold>d</bold>) The intensity of Pepstatin A staining within Purkinje cells was significantly decreased in SCA6 mice (p &lt; 0.0001; <italic>N</italic> = 3 WT mice, 78 cells; 3 SCA6 mice, 66 cells). ann–Whitney <italic>U</italic>-test used for all statistical comparisons, ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig6-v1.tif"/></fig></sec><sec id="s2-5"><title>7,8-DHF rescues deficits in early endosomes</title><p>We have previously shown that the putative TrkB agonist 7,8-DHF increases TrkB expression and activates Akt signaling downstream of TrkB, leading to a rescue of deficits in motor coordination and Purkinje cell firing in SCA6 mice (<xref ref-type="fig" rid="fig7">Figure 7a</xref>; <xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>). One interpretation of this rescue is that the TrkB agonist compensates for reduced levels of BDNF in the SCA6 cerebellum, thereby activating downstream signaling cascades to restore cerebellar function. However, we have also previously shown that TrkB activation with 7,8-DHF led to increased levels of TrkB in the SCA6 cerebellum (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>), suggesting that self-amplification of TrkB signaling may play a role in the rescue. 7,8-DHF may therefore not be simply replacing lost BDNF in SCA6. Indeed, there is some evidence that 7,8-DHF may act via antioxidant or anti-inflammatory effects independent of TrkB activation (<xref ref-type="bibr" rid="bib14">Chen et al., 2011</xref>; <xref ref-type="bibr" rid="bib25">Han et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Park et al., 2012</xref>). Given that TrkB signaling is known to be involved in the regulation and trafficking of endosomes (<xref ref-type="bibr" rid="bib56">Scott-Solomon and Kuruvilla, 2018</xref>), we wondered whether chronic oral administration of 7,8-DHF to SCA6 mice would rescue the deficits in early endosome size, either due to TrkB activation or another mechanism of action. We used the same treatment regimen of 7,8-DHF that had previously been shown to rescue deficits in behavior and Purkinje cell firing, which comprised of 1 month of oral administration of the drug to peri-onset (6- to 7-month-old) SCA6 mice (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). Half of the mice received control solution with no drug added. After 1 month of 7,8-DHF administration, cerebellar vermis sections were stained for BDNF and EEA1 as an early endosome marker, as previously described (<xref ref-type="fig" rid="fig2">Figure 2</xref>). 7,8-DHF administration rescued the size of the early endosomes, with the total EEA1 area within Purkinje cells reducing to the WT level previously described (<xref ref-type="fig" rid="fig7">Figure 7b, c</xref>). The level of BDNF accumulation within the early endosomes was also restored (<xref ref-type="fig" rid="fig7">Figure 7d</xref>), suggesting that in addition to self-amplifying upregulation of TrkB (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>), treatment with 7,8-DHF can normalize intracellular localization and trafficking of BDNF, consistent with the role of TrkB in regulating endosome trafficking and function (<xref ref-type="bibr" rid="bib56">Scott-Solomon and Kuruvilla, 2018</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Tropomyosin kinase B (TrkB) activation with 7,8-dihydroxyflavone (7,8-DHF) rescues early endosomes deficits in spinocerebellar ataxia type 6 (SCA6) Purkinje cells.</title><p>(<bold>a</bold>) Schematic showing 7,8-DHF administration to SCA6 mice and the previously described therapeutic benefits of 7,8-DHF in SCA6 mice. (<bold>b</bold>) Representative images of the early endosome marker EEA1 and brain-derived neurotrophic factor (BDNF) within Purkinje cells (outlined) of the anterior vermis. Scale bar, 10 µm. (<bold>c</bold>) The area covered by EEA1 staining in Purkinje cells is decreased in SCA6 mice given DHF compared to those that received control water (p &lt; 0.001; Student’s <italic>t</italic>-test; <italic>N</italic> = 3 SCA6 mice, 50 cells; 3 SCA6 DHF mice, 63 cells). (<bold>d</bold>) Relative staining level of BDNF within early endosome compartment is decreased in the Purkinje cells of SCA6 mice that received DHF compared to controls (p &lt; 0.001; Mann–Whitney <italic>U</italic>-test; <italic>N</italic> = 3 SCA6 mice, 50 cells; 3 SCA6 DHF mice, 63 cells). ***p &lt; 0.001.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig7-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have identified multiple novel deficits in the endo-lysosomal pathway that could contribute to BDNF–TrkB signaling alterations in SCA6 (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Early endosomes were enlarged in SCA6 and accumulate BDNF and TrkB. Recycling endosomes were morphologically normal but carried less TrkB, and late endosomes were reduced in size and carried less BDNF. This suggests that cargo is getting stuck in the enlarged early endosomes in SCA6. The involvement of lysosomal pathology in SCA6 is less clear. Lysosomes appear morphologically normal with normal pH, but RNA-sequencing revealed upregulation of lysosomal genes in SCA6. SCA6 Purkinje cells also showed a reduction in exogenous cargo binding to the lysosomal enzyme Cathepsin D, indicating either a deficit in lysosomal enzyme activity, defects in endocytosis and cargo trafficking to lysosomes, or both. Taken together, these deficits could lead to cellular dysfunction in SCA6. This work further highlights how BDNF and TrkB deficits manifest in SCA6, and the potential of targeting this pathway therapeutically.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Multiple deficits in the endo-lysosomal system lead to abnormal localization of brain-derived neurotrophic factor (BDNF) and tropomyosin kinase B (TrkB) in the Purkinje cells of spinocerebellar ataxia type 6 (SCA6) mice.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig8-v1.tif"/></fig><p>Excitingly, both the enlargement of early endosomes and the accumulation of BDNF in early endosomes could be rescued by the putative TrkB agonist, 7,8-DHF. There is evidence that TrkB can regulate its own expression and signaling (<xref ref-type="bibr" rid="bib15">Cheng et al., 2011</xref>; <xref ref-type="bibr" rid="bib24">Haapasalo et al., 2002</xref>) and we had previously shown that 7,8-DHF administration increased levels of TrkB in the cerebellum of SCA6 mice (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>). This new finding demonstrates that not only does 7,8-DHF regulate the expression of TrkB in the SCA6 cerebellum, but also the localization of the ligand for TrkB within endosomal compartments, providing insight into the mechanisms by which BDNF and TrkB are regulated in the cerebellum. Furthermore, the finding that 7,8-DHF can rescue endosomal deficits in SCA6 supports the promise of 7,8-DHF and related molecules as potential therapeutics for SCA6 and raises the possibility of their use for treatment of other disorders displaying early endosome deficits.</p><p>Early endosome deficits are not unique to SCA6, meaning that this finding may have a wider application. Enlargement of early endosomes is a hallmark of dysfunction in the endosomal pathway (<xref ref-type="bibr" rid="bib32">Kaur et al., 2018</xref>) and has been observed in multiple diseases including Alzheimer’s disease (<xref ref-type="bibr" rid="bib9">Cataldo et al., 2004</xref>; <xref ref-type="bibr" rid="bib8">Cataldo et al., 2000</xref>; <xref ref-type="bibr" rid="bib7">Cataldo et al., 1997</xref>; <xref ref-type="bibr" rid="bib62">Tate and Mathews, 2006</xref>), Down syndrome (<xref ref-type="bibr" rid="bib8">Cataldo et al., 2000</xref>), models of macular degeneration (<xref ref-type="bibr" rid="bib32">Kaur et al., 2018</xref>), Charcot–Marie–Tooth (<xref ref-type="bibr" rid="bib6">Bucci et al., 2012</xref>), and Parkinson’s disease (<xref ref-type="bibr" rid="bib65">Vidyadhara et al., 2019</xref>). Early endosome abnormalities can arise from deficits in maturation or fusion of early endosomes, or alterations in the microtubule networks that govern endosome fusion (<xref ref-type="bibr" rid="bib57">Skjeldal et al., 2012</xref>). Purkinje cells may be particularly susceptible to early endosome enlargement, as in postmortem tissue from Niemann Pick type C patients, Purkinje cells had enlarged early endosomes which accumulated amyloid precursor protein, whereas in the hippocampus, pathology mostly concerned late endosomes (<xref ref-type="bibr" rid="bib30">Jin et al., 2004</xref>). However, endosomal pathology in SCA6 and other diseases is not limited to early endosomes, and other endosomal compartments can be targeted therapeutically (<xref ref-type="bibr" rid="bib5">Bonam et al., 2019</xref>; <xref ref-type="bibr" rid="bib62">Tate and Mathews, 2006</xref>). In addition to identifying TrkB activation as a therapeutic strategy for endosome deficits, our work opens the door for the development of additional endosome-targeting treatment strategies for SCA6.</p><p>Our findings provide the first evidence for endosomal dysfunction contributing to signaling deficits in spinocerebellar ataxias. Other ataxias like SCA1 also have reduced BDNF protein levels (<xref ref-type="bibr" rid="bib45">Mellesmoen et al., 2018</xref>), so it would be interesting to determine whether early endosome deficits could contribute to disrupted BDNF signaling in other ataxias. Polyglutamine diseases in general are thought to have disruption in protein degradation pathways (<xref ref-type="bibr" rid="bib10">Chai et al., 1999</xref>; <xref ref-type="bibr" rid="bib18">Cortes and La Spada, 2015</xref>), and SCA7 patients and mouse models display alterations in lysosome pathways (<xref ref-type="bibr" rid="bib2">Alves et al., 2014</xref>). Therefore, similar abnormalities could be a common feature of similar diseases.</p><p>There remain, however, some unanswered questions from our study. What is the specific deficit that leads to early endosome enlargement and other deficits? Is it the same as in other neurological diseases? Future work to identify this will further aid in the development of endosome-targeting therapies. There is also the question of the effect on other cargo. Sorting and recycling happens in a cargo-specific manner (<xref ref-type="bibr" rid="bib26">Hu et al., 2015</xref>) and so other cargo could be handled differently. Here, we investigated endosomal trafficking of BDNF and TrkB as we have previously shown this pathway to be both dysregulated in SCA6, and amenable to therapeutic targeting. However, our experiments with BODIPY FL Pepstatin A suggest that even exogenous cargo could be transported differently in SCA6. Future research should consider whether other cargo accumulate in early endosomes and how this affects cell physiology. Furthermore, in parallel to endocytosis and endosome trafficking, cells transport proteins for degradation in lysosomes via autophagy (<xref ref-type="bibr" rid="bib35">Klionsky, 2005</xref>). There are therefore two pathways with a common destination of degradation in lysosomes, both of which are important for cell function, and abnormalities in one pathway can lead to disruption in the other (<xref ref-type="bibr" rid="bib4">Birgisdottir and Johansen, 2020</xref>; <xref ref-type="bibr" rid="bib42">Mahapatra et al., 2019</xref>). Future work should therefore investigate whether autophagy is disrupted in SCA6. Finally, while most of our study was conducted around disease onset, the transcriptomic alterations were measured at a later timepoint, which raises the question of whether transcriptional changes drive endo-lysosomal alterations or are in fact a result of endo-lysosomal changes that are caused by a different mechanism. A careful study of the timeline of these changes will help us understand the sequence of events as disease progresses in SCA6.</p><p>In summary, we have identified a dysregulated cellular trafficking pathway that contributes to cerebellar pathophysiology that is novel not just in SCA6, but in SCAs in general. We found that several components of the endo-lysosomal system show abnormalities in Purkinje cells in SCA6 mice. These deficits could contribute to BDNF–TrkB signaling deficits in SCA6, as BDNF and TrkB accumulate in early endosomes and there is a reduction in TrkB being recycled to the cell membrane for further signal transduction. The endo-lysosomal system is therefore a promising therapeutic target for SCA6.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Animals</title><p>As previously described, the SCA6<sup>84Q/84Q</sup> mouse model is a knock-in mouse with a humanized 84 CAG repeat expansion mutation at the <italic>CACNA1A</italic> locus (<xref ref-type="bibr" rid="bib28">Jayabal et al., 2015</xref>; <xref ref-type="bibr" rid="bib68">Watase et al., 2008</xref>). We bred heterozygous mice to generate SCA6<sup>84Q/84Q</sup> and litter-matched WT control mice. Breeding mice were originally purchased from Jackson laboratories (Bar Harbor, Maine; strain: B6.129S7-Cacna1atm3Hzo/J; stock number: 008683) and primer sequences for genotyping were provided by Jackson laboratories. This breeding setup allowed us to use experimental cohorts that contained litter- and sex-matched mice randomly assigned to experimental groups. Both male and female mice were included in all experiments, and we did not exclude any experimental animals from analysis, in accordance with ARRIVE guidelines. The only experiment that included pre-selection of mice was for RNA-sequencing where mice were selected for tissue collection based on rotarod performance, to include animals that were representative of their genotype. For all other experiments mice were selected at random and none were excluded. Animal husbandry and procedures were approved by the McGill Animal Care Committee (protocol 6082) in accordance with the Canadian Council on Animal Care guidelines. All staining experiments were carried out on tissue from mice aged 7–8 months of age, except the Lamp1 and Lysotracker staining which was carried out at 12 months of age.</p></sec><sec id="s4-2"><title>RNA extraction and sequencing</title><p>RNA extraction was performed on tissues from five WT (two male, three female) and five SCA6 (three male, two female) mice at 12 months of age. Experimental mice were selected based on rotarod performance in order to identify mice that were phenotypically representative of their genotype. The experimental area and tools were cleaned with RNAseZap (Sigma #R2020) to remove RNAse contamination prior to starting experiments. Mice were anesthetized with isoflurane until the loss of toe pinch reflex, decapitated and the cerebellar vermis was dissected, separated into anterior and posterior sections, flash frozen on dry ice, and stored at −80°C until RNA extraction. RNA extraction proceeded as follows, with all procedures carried out on ice or at 4°C. Cerebellar vermis tissue sections were mechanically homogenized in TRIzol reagent (Invitrogen #15596026) by passing the lysate repeatedly through a series of needles, starting at 18-gauge, followed by 23-gauge. Chloroform (Sigma #288306) was added to the homogenate to separate total RNA in the aqueous phase, and RNA was recovered by precipitation with ethanol (70%). RNA extracts were purified using the RNeasy Mini Kit (QIAGEN #74104) with DNase I treatment as described in the manufacturer’s protocol.</p><p>The RNA integrity of samples was quantified with capillary electrophoresis (Agilent BioAnalyzer 2100) in order to generate an RNA integrity number (RIN). All samples had an RIN over 7.5 and therefore were assessed to have high RNA quality. Library preparation and sequencing was carried out by Genome Quebec (Montreal, Quebec, Canada) using NEB stranded mRNA library prep, sequenced on the Illumina NovaSeq 6000 S4 generating 100 bp paired-end reads. Samples had a median of 53 million reads (Interquartile range [IQR], 42–64 million reads), and a median of 92% mapping rate (IQR, 92–92%).</p></sec><sec id="s4-3"><title>RNA-sequencing data analysis</title><p>The generated FASTQ files were transferred to the Digital Research Alliance of Canada cloud server for processing and analysis. First, reads were aligned to the mouse reference genome (GRCm38) using HISAT2 version 2.1.0 (<xref ref-type="bibr" rid="bib33">Kim et al., 2019</xref>). Quantification of reads was carried out with HTSeq version 0.11. (<xref ref-type="bibr" rid="bib3">Anders et al., 2015</xref>) in union mode. Reads generated from anterior and posterior samples were combined by addition at this step to generate an in silico whole cerebellar vermis read count. Differential expression analysis was performed with DESeq2 version 1.24.0 in RStudio (<xref ref-type="bibr" rid="bib40">Love et al., 2014</xref>). DESeq2 adjusted p values for multiple testing with a target <italic>ɑ</italic> = 0.05, and genes were considered to be differentially expressed genes at false discovery rate &lt;0.05. Enriched gene pathways were identified using gProfiler (<xref ref-type="bibr" rid="bib53">Raudvere et al., 2019</xref>) based on terms in GO databases.</p></sec><sec id="s4-4"><title>Immunohistochemistry</title><p>Tissue sections for IHC were prepared as described previously (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>). Mice were deeply anesthetized with 400 mg/kg 2,2,2-tribromoethanol (Avertin) prepared in sterile 0.85% saline for a working concentration of 20 mg/ml. Intracardiac perfusion comprised of a flush with 40 ml of heparin in phosphate-buffered saline (PBS; 0.1 M, pH 7) followed by 40 ml of 4% paraformaldehyde (PFA) in phosphate buffer (PB). Brains were rapidly removed and incubated in 4% PFA for a further 24 hr of fixation at 4°C on an orbital shaker at 70 RPM. Brains were dissected to separate the cerebellum and sliced using a vibrating microtome (5100mz Vibrotome, Campden Instruments, Loughborough, UK) into sections of 75 or 100 µm thickness. Slices were kept at 4°C in PBS with 0.05% sodium azide to inhibit microbial growth before staining.</p><p>Free-floating slices were rinsed with PBS and incubated in primary antibody (<xref ref-type="table" rid="table2">Table 2</xref>) and blocking solution with bovine serum albumin for 3 days, then rinsed in PBS and incubated for 90 min with secondary antibodies (<xref ref-type="table" rid="table2">Table 2</xref>). For experiments involving anti-mouse secondary antibodies, an additional incubation with Fab fragments (AffiniPure Fab Fragment Anti-Mouse IgG, Jackson Immunoresearch 715-007-003) was added prior to secondary antibody incubation. After a final PBS wash, stained slices were mounted using ProLong Gold Antifade mounting medium (Thermo Fisher Scientific, Waltham, USA) and stored at 4°C and protected from light prior to imaging.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>List of antibodies.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Antigen</th><th align="left" valign="bottom">Antibody (host)</th><th align="left" valign="bottom">Supplier</th><th align="left" valign="bottom">Catalog #</th><th align="left" valign="bottom">Dilution</th><th align="left" valign="bottom">Figure</th></tr></thead><tbody><tr><td align="left" valign="bottom">EEA1</td><td align="left" valign="bottom">Anti-EEA1 monoclonal (mouse)</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">E7659</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">2, 7, 9</td></tr><tr><td align="left" valign="bottom">BDNF</td><td align="left" valign="bottom">Anti-BDNF monoclonal (rabbit)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab108319</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">2, 4, 7, 9</td></tr><tr><td align="left" valign="bottom">TrkB</td><td align="left" valign="bottom">Anti-TrkB polyclonal (rabbit)</td><td align="left" valign="bottom">EMD Millipore</td><td align="left" valign="bottom">ab9872</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">2, 3, 9</td></tr><tr><td align="left" valign="bottom">Stx13</td><td align="left" valign="bottom">Anti-Stx13 polyclonal (goat)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">AF6617</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">3</td></tr><tr><td align="left" valign="bottom">Calbindin</td><td align="left" valign="bottom">Anti-calbindin polyclonal (guinea pig)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="char" char="." valign="bottom">214 004</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">2, 3, 6, 9</td></tr><tr><td align="left" valign="bottom">Rab7</td><td align="left" valign="bottom">Anti-Rab7 monoclonal (mouse)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="char" char="." valign="bottom">95746</td><td align="char" char="." valign="bottom">1:400</td><td align="char" char="." valign="bottom">4</td></tr><tr><td align="left" valign="bottom">Calbindin</td><td align="left" valign="bottom">Anti-calbindin monoclonal (mouse)</td><td align="left" valign="bottom">Swant</td><td align="char" char="." valign="bottom">300</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">5</td></tr><tr><td align="left" valign="bottom">Lamp1</td><td align="left" valign="bottom">Anti-Lamp1 monoclonal (rat)</td><td align="left" valign="bottom">DSHB (University of Iowa)<xref ref-type="table-fn" rid="table2fn1">*</xref></td><td align="char" char="." valign="bottom">1D4B</td><td align="char" char="." valign="bottom">1:400</td><td align="char" char="." valign="bottom">5, 6</td></tr><tr><td align="left" valign="bottom">Stx13</td><td align="left" valign="bottom">Anti-Stx13 polyclonal (rabbit)</td><td align="left" valign="bottom">Synaptic systems</td><td align="char" char="." valign="bottom">110 133</td><td align="char" char="." valign="bottom">1:150</td><td align="left" valign="bottom"><xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref></td></tr><tr><td align="left" valign="bottom">TrkB</td><td align="left" valign="bottom">Anti-TrkB polyclonal (rabbit)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab18987</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">9</td></tr><tr><td align="left" valign="bottom">Anti-mouse secondary</td><td align="left" valign="bottom">Alexa 488 anti-mouse</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">AB_2338840</td><td align="char" char="." valign="bottom">1:1000</td><td align="char" char="." valign="bottom">2, 7, 9</td></tr><tr><td align="left" valign="bottom">Anti-rabbit secondary</td><td align="left" valign="bottom">Alexa 594 anti-rabbit</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">AB_2340621</td><td align="char" char="." valign="bottom">1:1000</td><td align="char" char="." valign="bottom">2, 3, 7, 9</td></tr><tr><td align="left" valign="bottom">Anti-mouse secondary</td><td align="left" valign="bottom">Alexa 594 anti-mouse</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">AB_2338871</td><td align="char" char="." valign="bottom">1:1000</td><td align="char" char="." valign="bottom">4</td></tr><tr><td align="left" valign="bottom">Anti-rabbit secondary</td><td align="left" valign="bottom">Alexa 488 anti-rabbit</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">AB_2313584</td><td align="char" char="." valign="bottom">1:1000</td><td align="char" char="." valign="bottom">4</td></tr><tr><td align="left" valign="bottom">SAnti-rat secondary</td><td align="left" valign="bottom">Alexa 488 anti-rat</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">AB_2313584</td><td align="char" char="." valign="bottom">1:1000</td><td align="char" char="." valign="bottom">5</td></tr><tr><td align="left" valign="bottom">Anti-goat secondary</td><td align="left" valign="bottom">Alexa 488 anti-goat</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">AB_2340428</td><td align="char" char="." valign="bottom">1:1000</td><td align="char" char="." valign="bottom">3</td></tr><tr><td align="left" valign="bottom">Anti-mouse secondary</td><td align="left" valign="bottom">DyLight 405 anti-mouse</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="." valign="bottom">35501BID</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">5</td></tr><tr><td align="left" valign="bottom">Anti-guinea pig secondary</td><td align="left" valign="bottom">DyLight 405 anti-goat</td><td align="left" valign="bottom">Jackson Immunoresearch</td><td align="left" valign="bottom">AB_2340426</td><td align="char" char="." valign="bottom">1:500</td><td align="char" char="." valign="bottom">2, 3, 6, 9</td></tr></tbody></table><table-wrap-foot><fn id="table2fn1"><label>*</label><p>The LAMP-1 monoclonal antibody was obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at The University of Iowa, Department of Biology, Iowa City, IA 52242. It was deposited to the DSHB by August, J.T.</p></fn></table-wrap-foot></table-wrap><p>As previously described, we found that the anti-BDNF antibody required epitope retrieval procedures to be carried out prior to staining in order to obtain adequate staining. We additionally found that epitope retrieval enhanced staining with anti-EEA1. Epitope retrieval took the form of a heat-induced epitope retrieval (HIER) step involving heating the slices in PBS to 95°C for 10 min immediately prior to staining. Slices were allowed to cool and IHC procedures were carried out as normal. This greatly enhanced the quality of BDNF and EEA1 staining and allowed us to resolve intracellular endolysosomal structures in Purkinje cells (<xref ref-type="fig" rid="fig9">Figure 9a</xref>). HIER did not affect the staining of Purkinje cells with anti-calbindin (<xref ref-type="fig" rid="fig9">Figure 9a</xref>) and so the effect was specific to certain antigens and antibodies and not to the tissue in general.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Brain-derived neurotrophic factor (BDNF) immunostaining in the cerebellum requires heat-induced epitope retrieval (HIER) and is not detectable in the majority of liver tissue.</title><p>(<bold>a</bold>) HIER greatly enhances the signal from both BDNF and early endosome antigen 1 (EEA1) staining in cerebellar vermis tissue from wildtype (WT) and spinocerebellar ataxia type 6 (SCA6) mice. Calbindin staining is unaffected. Scale bars, 10 µm. (<bold>b</bold>) BDNF staining is undetectable in the majority of liver tissue from WT mouse, with only the BDNF-positive putative cholangiocytes (arrowheads) showing immunoreactivity with the BDNF antibody. Background slice was incubated without primary antibody but all other staining steps proceeded as normal. Scale bars, 20 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig9-v1.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>A second tropomyosin kinase B (TrkB) antibody confirms endosomal localization of TrkB.</title><p>Comparison of cerebellar vermis slices from the same wildtype (WT) mouse stained in the same batch show similar patterns of staining with two different TrkB antibodies. Arrowheads indicate TrkB colocalization with early endosome antigen 1 (EEA1). Scale bars, 10 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig9-figsupp1-v1.tif"/></fig><fig id="fig9s2" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 2.</label><caption><title>Autofluorescence granules in Purkinje cells do not interfere with endosome identification.</title><p>(<bold>a</bold>) Top row: raw images of brain-derived neurotrophic factor (BDNF) and early endosome antigen 1 (EEA1) staining in anterior vermis. Bottom row: raw images of slices from the same mice with no primary antibody incubation, showing autofluorescence from excitation at 561 and 488 nm. (<bold>b</bold>) Top row: raw images of Rab7 and BDNF staining in anterior vermis. Bottom row: raw images of slices from the same mice with no primary antibody incubation, showing autofluorescence from excitation at 561 and 488 nm. (<bold>c</bold>) Top row: raw images of Pepstatin A BODIPY FL incubation on acute slices that were post-fixed in paraformaldehyde (PFA). Bottom row: raw images of slices from the same mice with no Pepstatin A incubation, showing autofluorescence from excitation at 488 nm. Scale bars, 10 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90510-fig9-figsupp2-v1.tif"/></fig></fig-group><p>To further validate BDNF staining, we used liver tissue as a negative control. In rodent liver, the majority of tissue contains very low levels of BDNF (<xref ref-type="bibr" rid="bib36">Koppel et al., 2009</xref>; <xref ref-type="bibr" rid="bib67">Vivacqua et al., 2014</xref>), except from some BDNF-expressing cholangiocytes (<xref ref-type="bibr" rid="bib67">Vivacqua et al., 2014</xref>). We therefore used liver tissue from a WT mouse undergoing surgery for another project as a negative control to validate the BDNF antibody. The liver was recovered from the mouse during a terminal surgery and immediately placed into 4% PFA in PB for fixation. After 45 min of fixation the liver was sectioned into 100 µm slices using a vibrating microtome (5100mz Vibrotome, Campden Instruments, Loughborough, UK). These slices underwent HIER and BDNF staining as previously described. As expected, the majority of the liver tissue did not show BDNF immunoreactivity and we were able to detect putative cholangiocytes that were BDNF positive as previously described (<xref ref-type="fig" rid="fig9">Figure 9b</xref>).</p><p>To validate TrkB staining and confirm localization, a second TrkB antibody was used (<xref ref-type="table" rid="table2">Table 2</xref> for antibody information). We used cerebellar vermis tissue from a WT mouse to carry out TrkB staining using two different antibodies in the same batch and with all other reagents unchanged. We found that although the alternative antibody did not have as strong signal-to-noise ratio (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>), the TrkB staining displayed a similar localization and both antibodies were able to label TrkB in early endosomes within Purkinje cells.</p><p>Purkinje cells sometimes contained autofluorescent granules that were visible under excitation from a 561- or 488-nm laser even without primary antibody incubation (<xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2</xref>). In order to ascertain that these granules were not interfering with the identification of endosomes or lysosomes, staining batches included a negative control slice from each animal where applicable. These slices underwent all of the usual blocking steps except primary antibodies were not added, while secondary antibody incubation and mounting proceeded as usual. In the case of the Pepstatin A negative control, slices were incubated in artificial cerebrospinal fluid (ACSF) without Pepstatin A BODIPY FL, and all other steps proceeded as usual. We found that although there was some background fluorescence signal in Purkinje and other cells, the intensity of the signal was lower than the staining from the antibodies of interest and was unlikely to interfere significantly with image analysis. This can be seen in side-by-side comparisons of raw images from the same mice in <xref ref-type="fig" rid="fig9">Figure 9</xref>, <xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2</xref>.</p></sec><sec id="s4-5"><title>Lysotracker</title><p>Lysotracker staining was carried out on acute cerebellar slices. Mice were anesthetized with isoflurane until the loss of toe pinch reflex and then were decapitated into ice cold ACSF (125 mM NaCl, 2.5 mM KCl, 2 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 26 mM NaHCO<sub>3</sub>, and 20 mM glucose, bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub> (carbogen) to maintain pH at 7.3; osmolality ~316 mOsm). The brain was removed and dissected, and the cerebellar vermis was sectioned into 150 µm sagittal slices using a VT 1200S vibratome (Leica Microsystems, Wetzlar, Germany) in ice cold ACSF. Slices were transferred to a slice chamber filled with 37°C ACSF bubbled with carbogen for 40 min before staining. Slices were then incubated in LysoTracker Red DND-99 (Thermo Fisher L7528) that was dissolved in room temperature ACSF at a concentration of 1:3000. Incubation occurred at room temperature on an orbital shaker at 70 RPM. After 5 min of incubation the slices were transferred to 4% PFA in PB for post-fixation at 70 RPM for 1 hr. Slices were then washed in PBS and prepared for IHC as outlined above.</p></sec><sec id="s4-6"><title>Pepstatin A</title><p>Pepstatin A imaging was carried out on acute cerebellar slices prepared in the same way as for the Lysotracker imaging outlined above. After slices were kept in 37°C ACSF bubbled with carbogen for 40 min they were incubated in Pepstatin A fl BODIPY (Thermo Fisher P12271) that was prepared at a concentration of 1 µg/ml in room temperature ACSF. A stock solution of 1 µg/1 µl pepstatin A in Dimethylsulfoxide (DMSO) was prepared, to improve solubility, giving a final concentration of 0.001% DMSO in the incubation solution. Incubation lasted 30 min at room temperature on an orbital shaker at 70 RPM. Slices were then rinsed twice with PBS and transferred to 4% PFA for post-fixation at 70 RPM for 30 min. Slices either underwent further staining with IHC for Lamp1 and calbindin or were mounted onto slides immediately using ProLong Gold Antifade mounting medium (Thermo Fisher Scientific, Waltham, USA) and stored at 4°C and protected from light.</p></sec><sec id="s4-7"><title>Image acquisition</title><p>Imaging was performed using an LSM800 confocal microscope (Zeiss) equipped with Zen Blue software. Images were acquired using ×63 and ×40 objectives at 1024 × 1024-pixel resolution. Imaging was carried out by an experimenter who was blinded to the experimental condition of the slides. All imaging and analysis were carried out in lobule 3 of the anterior vermis, a region of the cerebellum that we have previously shown to display cellular deficits in SCA6 (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Jayabal et al., 2015</xref>).</p></sec><sec id="s4-8"><title>Image analysis</title><p>Image analysis was performed in FIJI (ImageJ; US National Institutes of Health) (<xref ref-type="bibr" rid="bib54">Rueden et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Schindelin et al., 2012</xref>). Purkinje cell bodies were delineated by hand using calbindin or BDNF as a marker so that the Purkinje cell soma area could be isolated for further analysis. To calculate the area of the endosomes or lysosomes, an Otsu thresholding function of the endosomal marker was used. Despeckle and watershed functions were applied to create a region of interest consisting of the relevant endosomal compartment within the cell. These regions were used to calculate the size of different compartments, and in the analysis of lysosomes the area of colocalization between regions of interest was calculated. The regions of interest delineated with various markers were subsequently used as a mask to measure fluorescence intensity levels of the cargo of interest. The cargo level was calculated using the integrated density measurement in ImageJ within the region of interest delineating the compartment of interest, and all values were normalized to the mean WT value. In <xref ref-type="fig" rid="fig7">Figure 7</xref>, values were normalized to the mean SCA6 control value. Analysis was carried out using custom ImageJ macros alongside manual verification.</p><p>For additional analysis of the lysosomes, we performed manual counts of Lamp1- and Lysotracker-positive organelles within individual Purkinje cells.</p><p>To improve the legibility of figure panels, linear adjustments of the brightness and contrast were applied to some representative image sets. Adjustments were kept to a minimum and identical adjustments were applied to images from all conditions, occurring after image analysis. Image analysis was performed on raw images by an experimenter blinded to the experimental condition of the slides.</p></sec><sec id="s4-9"><title>7,8-DHF administration</title><p>7,8-DHF administration was carried out as previously described (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>), as we had previously found this treatment regimen to be both well tolerated and effective at restoring TrkB–Akt signaling in SCA6 mice. Briefly, single-housed mice were provided with ad libitum access to drug solutions in place of their drinking water for 1 month. These solutions contained either 157.3 µM 7,8-DHF (TCI America) dissolved in 0.04% DMSO vehicle (Sigma, Oakville, ON, Canada) or 0.04% DMSO only as a control, dissolved in autoclaved water with 10% sucrose (Sigma, Oakville, ON, Canada) added to make the solutions palatable and disguise any taste of the drug. Solutions were prepared fresh at least twice weekly and replenished daily. It has been shown by us and others that oral administration of 7,8-DHF is sufficient to induce signaling changes in the brain (<xref ref-type="bibr" rid="bib17">Cook et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Gao et al., 2016</xref>; <xref ref-type="bibr" rid="bib31">Johnson et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Parrini et al., 2017</xref>; <xref ref-type="bibr" rid="bib71">Zhang et al., 2014</xref>) and the drug has been shown to be orally bioavailable (<xref ref-type="bibr" rid="bib38">Liu et al., 2013</xref>).</p></sec><sec id="s4-10"><title>Statistical analysis</title><p>Pairwise statistical comparisons were carried out to identify statistical differences between groups. In cases where the data were normally distributed, Student’s <italic>t</italic>-tests were used, otherwise Mann–Whitney <italic>U</italic>-tests were used. The type of statistical test and the sample size is indicated in the figure legend for each plot. All violin plots show individual cells as data points, with the median displayed as a horizontal line.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Investigation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Funding acquisition, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal husbandry and procedures were approved by the McGill Animal Care Committee in accordance with the Canadian Council on Animal Care guidelines (protocol 6082).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-90510-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Source data files have been provided for Figure 1.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to thank all members of the Watt lab for helpful discussions and feedback on experiments, particularly to Kim Gruver for feedback on an earlier draft of this manuscript. Thank you to Anne McKinney, Louis-Charles Masson, and Andy Gao for advice and guidance throughout the project. Thank you to Rose Bagot for technical advice regarding the RNA-sequencing experiment.</p><p>We are grateful to Lois Lau and Anika Holur for carrying out genotyping and to Tanya Koch and all CMARC staff for animal colony support. Imaging was carried out in the McGill University Advanced BioImaging Facility (ABIF), RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_017697">SCR_017697</ext-link> and we thank ABIF staff members for technical support. This research was enabled in part by support provided by Calcul Québec (calculquebec.ca) and the Digital Research Alliance of Canada (alliancecan.ca). This work was funded by a CIHR project grant (PJT-153150) (AJW). Student support came from doctoral awards from the Fonds de recherche du Québec – Santé (AAC and TCSL), a MITACS training award (AAC), a McGill science undergraduate research award (MR), and a McGill Biology research award (ÉZD).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akizu</surname><given-names>N</given-names></name><name><surname>Cantagrel</surname><given-names>V</given-names></name><name><surname>Zaki</surname><given-names>MS</given-names></name><name><surname>Al-Gazali</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Rosti</surname><given-names>RO</given-names></name><name><surname>Dikoglu</surname><given-names>E</given-names></name><name><surname>Gelot</surname><given-names>AB</given-names></name><name><surname>Rosti</surname><given-names>B</given-names></name><name><surname>Vaux</surname><given-names>KK</given-names></name><name><surname>Scott</surname><given-names>EM</given-names></name><name><surname>Silhavy</surname><given-names>JL</given-names></name><name><surname>Schroth</surname><given-names>J</given-names></name><name><surname>Copeland</surname><given-names>B</given-names></name><name><surname>Schaffer</surname><given-names>AE</given-names></name><name><surname>Gordts</surname><given-names>P</given-names></name><name><surname>Esko</surname><given-names>JD</given-names></name><name><surname>Buschman</surname><given-names>MD</given-names></name><name><surname>Field</surname><given-names>SJ</given-names></name><name><surname>Napolitano</surname><given-names>G</given-names></name><name><surname>Abdel-Salam</surname><given-names>GM</given-names></name><name><surname>Ozgul</surname><given-names>RK</given-names></name><name><surname>Sagıroglu</surname><given-names>MS</given-names></name><name><surname>Azam</surname><given-names>M</given-names></name><name><surname>Ismail</surname><given-names>S</given-names></name><name><surname>Aglan</surname><given-names>M</given-names></name><name><surname>Selim</surname><given-names>L</given-names></name><name><surname>Mahmoud</surname><given-names>IG</given-names></name><name><surname>Abdel-Hadi</surname><given-names>S</given-names></name><name><surname>Badawy</surname><given-names>AE</given-names></name><name><surname>Sadek</surname><given-names>AA</given-names></name><name><surname>Mojahedi</surname><given-names>F</given-names></name><name><surname>Kayserili</surname><given-names>H</given-names></name><name><surname>Masri</surname><given-names>A</given-names></name><name><surname>Bastaki</surname><given-names>L</given-names></name><name><surname>Temtamy</surname><given-names>S</given-names></name><name><surname>Müller</surname><given-names>U</given-names></name><name><surname>Desguerre</surname><given-names>I</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Dursun</surname><given-names>A</given-names></name><name><surname>Gunel</surname><given-names>M</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>de Lonlay</surname><given-names>P</given-names></name><name><surname>Gleeson</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Biallelic mutations in SNX14 cause a syndromic form of cerebellar atrophy and lysosome-autophagosome dysfunction</article-title><source>Nature Genetics</source><volume>47</volume><fpage>528</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1038/ng.3256</pub-id><pub-id pub-id-type="pmid">25848753</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>S</given-names></name><name><surname>Cormier-Dequaire</surname><given-names>F</given-names></name><name><surname>Marinello</surname><given-names>M</given-names></name><name><surname>Marais</surname><given-names>T</given-names></name><name><surname>Muriel</surname><given-names>MP</given-names></name><name><surname>Beaumatin</surname><given-names>F</given-names></name><name><surname>Charbonnier-Beaupel</surname><given-names>F</given-names></name><name><surname>Tahiri</surname><given-names>K</given-names></name><name><surname>Seilhean</surname><given-names>D</given-names></name><name><surname>El Hachimi</surname><given-names>K</given-names></name><name><surname>Ruberg</surname><given-names>M</given-names></name><name><surname>Stevanin</surname><given-names>G</given-names></name><name><surname>Barkats</surname><given-names>M</given-names></name><name><surname>den Dunnen</surname><given-names>W</given-names></name><name><surname>Priault</surname><given-names>M</given-names></name><name><surname>Brice</surname><given-names>A</given-names></name><name><surname>Durr</surname><given-names>A</given-names></name><name><surname>Corvol</surname><given-names>JC</given-names></name><name><surname>Sittler</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice</article-title><source>Acta Neuropathologica</source><volume>128</volume><fpage>705</fpage><lpage>722</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1289-8</pub-id><pub-id pub-id-type="pmid">24859968</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Pyl</surname><given-names>PT</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HTSeq--a Python framework to work with high-throughput sequencing data</article-title><source>Bioinformatics</source><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id><pub-id pub-id-type="pmid">25260700</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birgisdottir</surname><given-names>ÅB</given-names></name><name><surname>Johansen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Autophagy and endocytosis - interconnections and interdependencies</article-title><source>Journal of Cell Science</source><volume>133</volume><elocation-id>jcs228114</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.228114</pub-id><pub-id pub-id-type="pmid">32501285</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonam</surname><given-names>SR</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Muller</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lysosomes as a therapeutic target</article-title><source>Nature Reviews. Drug Discovery</source><volume>18</volume><fpage>923</fpage><lpage>948</lpage><pub-id pub-id-type="doi">10.1038/s41573-019-0036-1</pub-id><pub-id pub-id-type="pmid">31477883</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bucci</surname><given-names>C</given-names></name><name><surname>Bakke</surname><given-names>O</given-names></name><name><surname>Progida</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Charcot-Marie-Tooth disease and intracellular traffic</article-title><source>Progress in Neurobiology</source><volume>99</volume><fpage>191</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2012.03.003</pub-id><pub-id pub-id-type="pmid">22465036</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cataldo</surname><given-names>AM</given-names></name><name><surname>Barnett</surname><given-names>JL</given-names></name><name><surname>Pieroni</surname><given-names>C</given-names></name><name><surname>Nixon</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer’s disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis</article-title><source>The Journal of Neuroscience</source><volume>17</volume><fpage>6142</fpage><lpage>6151</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-16-06142.1997</pub-id><pub-id pub-id-type="pmid">9236226</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cataldo</surname><given-names>AM</given-names></name><name><surname>Peterhoff</surname><given-names>CM</given-names></name><name><surname>Troncoso</surname><given-names>JC</given-names></name><name><surname>Gomez-Isla</surname><given-names>T</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Nixon</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer’s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations</article-title><source>The American Journal of Pathology</source><volume>157</volume><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1016/s0002-9440(10)64538-5</pub-id><pub-id pub-id-type="pmid">10880397</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cataldo</surname><given-names>AM</given-names></name><name><surname>Petanceska</surname><given-names>S</given-names></name><name><surname>Terio</surname><given-names>NB</given-names></name><name><surname>Peterhoff</surname><given-names>CM</given-names></name><name><surname>Durham</surname><given-names>R</given-names></name><name><surname>Mercken</surname><given-names>M</given-names></name><name><surname>Mehta</surname><given-names>PD</given-names></name><name><surname>Buxbaum</surname><given-names>J</given-names></name><name><surname>Haroutunian</surname><given-names>V</given-names></name><name><surname>Nixon</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome</article-title><source>Neurobiology of Aging</source><volume>25</volume><fpage>1263</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.02.027</pub-id><pub-id pub-id-type="pmid">15465622</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>Y</given-names></name><name><surname>Koppenhafer</surname><given-names>SL</given-names></name><name><surname>Shoesmith</surname><given-names>SJ</given-names></name><name><surname>Perez</surname><given-names>MK</given-names></name><name><surname>Paulson</surname><given-names>HL</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro</article-title><source>Human Molecular Genetics</source><volume>8</volume><fpage>673</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1093/hmg/8.4.673</pub-id><pub-id pub-id-type="pmid">10072437</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HHV</given-names></name><name><surname>Cook</surname><given-names>AA</given-names></name><name><surname>Watt</surname><given-names>AJ</given-names></name><name><surname>Cullen</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Loss of Flocculus Purkinje Cell firing precision leads to impaired Gaze Stabilization in a Mouse Model of Spinocerebellar Ataxia Type 6 (SCA6)</article-title><source>Cells</source><volume>11</volume><elocation-id>2739</elocation-id><pub-id pub-id-type="doi">10.3390/cells11172739</pub-id><pub-id pub-id-type="pmid">36078147</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chazotte</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Labeling lysosomes in live cells with LysoTracker</article-title><source>Cold Spring Harbor Protocols</source><volume>2011</volume><elocation-id>5571</elocation-id><pub-id pub-id-type="doi">10.1101/pdb.prot5571</pub-id><pub-id pub-id-type="pmid">21285271</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CS</given-names></name><name><surname>Chen</surname><given-names>WN</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Arttamangkul</surname><given-names>S</given-names></name><name><surname>Haugland</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Probing the cathepsin D using A BODIPY FL-pepstatin A: applications in fluorescence polarization and microscopy</article-title><source>Journal of Biochemical and Biophysical Methods</source><volume>42</volume><fpage>137</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/s0165-022x(00)00048-8</pub-id><pub-id pub-id-type="pmid">10737220</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chua</surname><given-names>KW</given-names></name><name><surname>Chua</surname><given-names>CC</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Pei</surname><given-names>A</given-names></name><name><surname>Chua</surname><given-names>BHL</given-names></name><name><surname>Hamdy</surname><given-names>RC</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Antioxidant activity of 7,8-dihydroxyflavone provides neuroprotection against glutamate-induced toxicity</article-title><source>Neuroscience Letters</source><volume>499</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2011.05.054</pub-id><pub-id pub-id-type="pmid">21651962</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>PL</given-names></name><name><surname>Song</surname><given-names>AH</given-names></name><name><surname>Wong</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Poo</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Self-amplifying autocrine actions of BDNF in axon development</article-title><source>PNAS</source><volume>108</volume><fpage>18430</fpage><lpage>18435</lpage><pub-id pub-id-type="doi">10.1073/pnas.1115907108</pub-id><pub-id pub-id-type="pmid">22025720</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>XT</given-names></name><name><surname>Xie</surname><given-names>YX</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>N</given-names></name><name><surname>Farfel-Becker</surname><given-names>T</given-names></name><name><surname>Sheng</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Revisiting LAMP1 as a marker for degradative autophagy-lysosomal organelles in the nervous system</article-title><source>Autophagy</source><volume>14</volume><fpage>1472</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1080/15548627.2018.1482147</pub-id><pub-id pub-id-type="pmid">29940787</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>AA</given-names></name><name><surname>Jayabal</surname><given-names>S</given-names></name><name><surname>Sheng</surname><given-names>J</given-names></name><name><surname>Fields</surname><given-names>E</given-names></name><name><surname>Leung</surname><given-names>TCS</given-names></name><name><surname>Quilez</surname><given-names>S</given-names></name><name><surname>McNicholas</surname><given-names>E</given-names></name><name><surname>Lau</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Watt</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6</article-title><source>Science Advances</source><volume>8</volume><elocation-id>eabh3260</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abh3260</pub-id><pub-id pub-id-type="pmid">36112675</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortes</surname><given-names>CJ</given-names></name><name><surname>La Spada</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?</article-title><source>Molecular and Cellular Neurosciences</source><volume>66</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2015.03.010</pub-id><pub-id pub-id-type="pmid">25771431</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Duve</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The lysosome turns fifty</article-title><source>Nature Cell Biology</source><volume>7</volume><fpage>847</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1038/ncb0905-847</pub-id><pub-id pub-id-type="pmid">16136179</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Rinaldo</surname><given-names>L</given-names></name><name><surname>Lamar</surname><given-names>KM</given-names></name><name><surname>Palmenberg</surname><given-names>AC</given-names></name><name><surname>Hansel</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6</article-title><source>Cell</source><volume>154</volume><fpage>118</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.059</pub-id><pub-id pub-id-type="pmid">23827678</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><name><surname>Hejazi Pastor</surname><given-names>DP</given-names></name><name><surname>Rao</surname><given-names>ER</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Grasselli</surname><given-names>G</given-names></name><name><surname>Godfrey</surname><given-names>J</given-names></name><name><surname>Palmenberg</surname><given-names>AC</given-names></name><name><surname>Andrade</surname><given-names>J</given-names></name><name><surname>Hansel</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>α1ACT Is essential for survival and early cerebellar programming in a Critical Neonatal Window</article-title><source>Neuron</source><volume>102</volume><fpage>770</fpage><lpage>785</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.036</pub-id><pub-id pub-id-type="pmid">30922876</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>SF</given-names></name><name><surname>Irmady</surname><given-names>K</given-names></name><name><surname>Ostrow</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Nykjaer</surname><given-names>A</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><name><surname>Blobel</surname><given-names>C</given-names></name><name><surname>Hempstead</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation</article-title><source>The Journal of Biological Chemistry</source><volume>286</volume><fpage>29556</fpage><lpage>29567</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.219675</pub-id><pub-id pub-id-type="pmid">21730062</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Tian</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>HY</given-names></name><name><surname>Xu</surname><given-names>QQ</given-names></name><name><surname>Huang</surname><given-names>YM</given-names></name><name><surname>Si</surname><given-names>QC</given-names></name><name><surname>Tian</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>QM</given-names></name><name><surname>Hu</surname><given-names>XM</given-names></name><name><surname>Sun</surname><given-names>LB</given-names></name><name><surname>McClintock</surname><given-names>SM</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer’s disease</article-title><source>Journal of Neurochemistry</source><volume>136</volume><fpage>620</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1111/jnc.13432</pub-id><pub-id pub-id-type="pmid">26577931</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haapasalo</surname><given-names>A</given-names></name><name><surname>Sipola</surname><given-names>I</given-names></name><name><surname>Larsson</surname><given-names>K</given-names></name><name><surname>Akerman</surname><given-names>KEO</given-names></name><name><surname>Stoilov</surname><given-names>P</given-names></name><name><surname>Stamm</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Castren</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRKB isoforms</article-title><source>The Journal of Biological Chemistry</source><volume>277</volume><fpage>43160</fpage><lpage>43167</lpage><pub-id pub-id-type="doi">10.1074/jbc.M205202200</pub-id><pub-id pub-id-type="pmid">12202482</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Yao</surname><given-names>W</given-names></name><name><surname>Qu</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity</article-title><source>Neurochemistry International</source><volume>64</volume><fpage>18</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2013.10.018</pub-id><pub-id pub-id-type="pmid">24220540</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>YB</given-names></name><name><surname>Dammer</surname><given-names>EB</given-names></name><name><surname>Ren</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration</article-title><source>Translational Neurodegeneration</source><volume>4</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/s40035-015-0041-1</pub-id><pub-id pub-id-type="pmid">26448863</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huotari</surname><given-names>J</given-names></name><name><surname>Helenius</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Endosome maturation</article-title><source>The EMBO Journal</source><volume>30</volume><fpage>3481</fpage><lpage>3500</lpage><pub-id pub-id-type="doi">10.1038/emboj.2011.286</pub-id><pub-id pub-id-type="pmid">21878991</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayabal</surname><given-names>S</given-names></name><name><surname>Ljungberg</surname><given-names>L</given-names></name><name><surname>Erwes</surname><given-names>T</given-names></name><name><surname>Cormier</surname><given-names>A</given-names></name><name><surname>Quilez</surname><given-names>S</given-names></name><name><surname>El Jaouhari</surname><given-names>S</given-names></name><name><surname>Watt</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rapid onset of motor deficits in a Mouse Model of Spinocerebellar Ataxia Type 6 Precedes Late Cerebellar Degeneration</article-title><source>eNeuro</source><volume>2</volume><elocation-id>ENEURO.0094-15.2015</elocation-id><pub-id pub-id-type="doi">10.1523/ENEURO.0094-15.2015</pub-id><pub-id pub-id-type="pmid">26730403</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayabal</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>HHV</given-names></name><name><surname>Cullen</surname><given-names>KE</given-names></name><name><surname>Watt</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>29489</elocation-id><pub-id pub-id-type="doi">10.1038/srep29489</pub-id><pub-id pub-id-type="pmid">27381005</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>LW</given-names></name><name><surname>Shie</surname><given-names>FS</given-names></name><name><surname>Maezawa</surname><given-names>I</given-names></name><name><surname>Vincent</surname><given-names>I</given-names></name><name><surname>Bird</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities</article-title><source>The American Journal of Pathology</source><volume>164</volume><fpage>975</fpage><lpage>985</lpage><pub-id pub-id-type="doi">10.1016/s0002-9440(10)63185-9</pub-id><pub-id pub-id-type="pmid">14982851</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>RA</given-names></name><name><surname>Lam</surname><given-names>M</given-names></name><name><surname>Punzo</surname><given-names>AM</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>BR</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Mitchell</surname><given-names>GS</given-names></name><name><surname>Chang</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>7,8-dihydroxyflavone exhibits therapeutic efficacy in a mouse model of Rett syndrome</article-title><source>Journal of Applied Physiology</source><volume>112</volume><fpage>704</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01361.2011</pub-id><pub-id pub-id-type="pmid">22194327</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Tan</surname><given-names>LX</given-names></name><name><surname>Rathnasamy</surname><given-names>G</given-names></name><name><surname>La Cunza</surname><given-names>N</given-names></name><name><surname>Germer</surname><given-names>CJ</given-names></name><name><surname>Toops</surname><given-names>KA</given-names></name><name><surname>Fernandes</surname><given-names>M</given-names></name><name><surname>Blenkinsop</surname><given-names>TA</given-names></name><name><surname>Lakkaraju</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Aberrant early endosome biogenesis mediates complement activation in the retinal pigment epithelium in models of macular degeneration</article-title><source>PNAS</source><volume>115</volume><fpage>9014</fpage><lpage>9019</lpage><pub-id pub-id-type="doi">10.1073/pnas.1805039115</pub-id><pub-id pub-id-type="pmid">30126999</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Paggi</surname><given-names>JM</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><name><surname>Bennett</surname><given-names>C</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype</article-title><source>Nature Biotechnology</source><volume>37</volume><fpage>907</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1038/s41587-019-0201-4</pub-id><pub-id pub-id-type="pmid">31375807</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Ochoa</surname><given-names>K</given-names></name><name><surname>Melli</surname><given-names>SE</given-names></name><name><surname>Yousufzai</surname><given-names>FAK</given-names></name><name><surname>Barrera</surname><given-names>ZD</given-names></name><name><surname>Williams</surname><given-names>AA</given-names></name><name><surname>McIntyre</surname><given-names>G</given-names></name><name><surname>Delgado</surname><given-names>E</given-names></name><name><surname>Bolish</surname><given-names>JN</given-names></name><name><surname>Macleod</surname><given-names>CM</given-names></name><name><surname>Boghos</surname><given-names>M</given-names></name><name><surname>Lens</surname><given-names>HP</given-names></name><name><surname>Ramos</surname><given-names>AG</given-names></name><name><surname>Wilson</surname><given-names>VB</given-names></name><name><surname>Maloney</surname><given-names>K</given-names></name><name><surname>Padron</surname><given-names>ZM</given-names></name><name><surname>Khan</surname><given-names>AH</given-names></name><name><surname>Blanco</surname><given-names>RE</given-names></name><name><surname>Soto</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Disruptive lysosomal-metabolic signaling and neurodevelopmental deficits that precede Purkinje cell loss in a mouse model of Niemann-Pick Type-C disease</article-title><source>Scientific Reports</source><volume>13</volume><elocation-id>5665</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-023-32971-0</pub-id><pub-id pub-id-type="pmid">37024714</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klionsky</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Autophagy</article-title><source>Current Biology</source><volume>15</volume><fpage>R282</fpage><lpage>R283</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2005.04.013</pub-id><pub-id pub-id-type="pmid">15854889</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppel</surname><given-names>I</given-names></name><name><surname>Aid-Pavlidis</surname><given-names>T</given-names></name><name><surname>Jaanson</surname><given-names>K</given-names></name><name><surname>Sepp</surname><given-names>M</given-names></name><name><surname>Pruunsild</surname><given-names>P</given-names></name><name><surname>Palm</surname><given-names>K</given-names></name><name><surname>Timmusk</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tissue-specific and neural activity-regulated expression of human BDNF gene in BAC transgenic mice</article-title><source>BMC Neuroscience</source><volume>10</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2202-10-68</pub-id><pub-id pub-id-type="pmid">19555478</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>RE</given-names></name><name><surname>Zoncu</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The lysosome as a cellular centre for signalling, metabolism and quality control</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1038/s41556-018-0244-7</pub-id><pub-id pub-id-type="pmid">30602725</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>HR</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>O-methylated metabolite of 7,8-dihydroxyflavone activates TrkB receptor and displays antidepressant activity</article-title><source>Pharmacology</source><volume>91</volume><fpage>185</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1159/000346920</pub-id><pub-id pub-id-type="pmid">23445871</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>CB</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders</article-title><source>Translational Neurodegeneration</source><volume>5</volume><elocation-id>2</elocation-id><pub-id pub-id-type="doi">10.1186/s40035-015-0048-7</pub-id><pub-id pub-id-type="pmid">26740873</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>T</given-names></name><name><surname>Griffiths</surname><given-names>G</given-names></name><name><surname>Hoflack</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Distribution of newly synthesized lysosomal enzymes in the endocytic pathway of normal rat kidney cells</article-title><source>The Journal of Cell Biology</source><volume>115</volume><fpage>1561</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1083/jcb.115.6.1561</pub-id><pub-id pub-id-type="pmid">1661730</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahapatra</surname><given-names>KK</given-names></name><name><surname>Panigrahi</surname><given-names>DP</given-names></name><name><surname>Praharaj</surname><given-names>PP</given-names></name><name><surname>Bhol</surname><given-names>CS</given-names></name><name><surname>Patra</surname><given-names>S</given-names></name><name><surname>Mishra</surname><given-names>SR</given-names></name><name><surname>Behera</surname><given-names>BP</given-names></name><name><surname>Bhutia</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Molecular interplay of autophagy and endocytosis in human health and diseases</article-title><source>Biological Reviews of the Cambridge Philosophical Society</source><volume>94</volume><fpage>1576</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1111/brv.12515</pub-id><pub-id pub-id-type="pmid">30989802</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majzoub</surname><given-names>RN</given-names></name><name><surname>Wonder</surname><given-names>E</given-names></name><name><surname>Ewert</surname><given-names>KK</given-names></name><name><surname>Kotamraju</surname><given-names>VR</given-names></name><name><surname>Teesalu</surname><given-names>T</given-names></name><name><surname>Safinya</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Rab11 and Lysotracker Markers Reveal Correlation between Endosomal Pathways and Transfection Efficiency of Surface-Functionalized Cationic Liposome-DNA Nanoparticles</article-title><source>The Journal of Physical Chemistry. B</source><volume>120</volume><fpage>6439</fpage><lpage>6453</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.6b04441</pub-id><pub-id pub-id-type="pmid">27203598</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannan</surname><given-names>AU</given-names></name><name><surname>Roussa</surname><given-names>E</given-names></name><name><surname>Kraus</surname><given-names>C</given-names></name><name><surname>Rickmann</surname><given-names>M</given-names></name><name><surname>Maenner</surname><given-names>J</given-names></name><name><surname>Nayernia</surname><given-names>K</given-names></name><name><surname>Krieglstein</surname><given-names>K</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name><name><surname>Engel</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mutation in the gene encoding lysosomal acid phosphatase (Acp2) causes cerebellum and skin malformation in mouse</article-title><source>Neurogenetics</source><volume>5</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1007/s10048-004-0197-9</pub-id><pub-id pub-id-type="pmid">15503243</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellesmoen</surname><given-names>A</given-names></name><name><surname>Sheeler</surname><given-names>C</given-names></name><name><surname>Ferro</surname><given-names>A</given-names></name><name><surname>Rainwater</surname><given-names>O</given-names></name><name><surname>Cvetanovic</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Brain Derived Neurotrophic Factor (BDNF) Delays Onset of Pathogenesis in Transgenic Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>509</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00509</pub-id><pub-id pub-id-type="pmid">30718999</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya-Alvarado</surname><given-names>G</given-names></name><name><surname>Gonzalez</surname><given-names>A</given-names></name><name><surname>Stuardo</surname><given-names>N</given-names></name><name><surname>Bronfman</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Brain-Derived Neurotrophic Factor (BDNF) Regulates Rab5-Positive Early Endosomes in Hippocampal Neurons to Induce Dendritic Branching</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>493</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00493</pub-id><pub-id pub-id-type="pmid">30618640</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moya-Alvarado</surname><given-names>G</given-names></name><name><surname>Tiburcio-Felix</surname><given-names>R</given-names></name><name><surname>Ibáñez</surname><given-names>MR</given-names></name><name><surname>Aguirre-Soto</surname><given-names>AA</given-names></name><name><surname>Guerra</surname><given-names>MV</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Mobley</surname><given-names>WC</given-names></name><name><surname>Perlson</surname><given-names>E</given-names></name><name><surname>Bronfman</surname><given-names>FC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>BDNF/TrkB signaling endosomes in axons coordinate CREB/mTOR activation and protein synthesis in the cell body to induce dendritic growth in cortical neurons</article-title><source>eLife</source><volume>12</volume><elocation-id>e77455</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.77455</pub-id><pub-id pub-id-type="pmid">36826992</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Sullivan</surname><given-names>MJ</given-names></name><name><surname>Lindsay</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The Endosomal Recycling Pathway-At the Crossroads of the Cell</article-title><source>International Journal of Molecular Sciences</source><volume>21</volume><elocation-id>6074</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21176074</pub-id><pub-id pub-id-type="pmid">32842549</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>GY</given-names></name><name><surname>Hyun</surname><given-names>JW</given-names></name><name><surname>Hwang</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>ND</given-names></name><name><surname>Kim</surname><given-names>BW</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>7,8-Dihydroxyflavone exhibits anti-inflammatory properties by downregulating the NF-κB and MAPK signaling pathways in lipopolysaccharide-treated RAW264.7 cells</article-title><source>International Journal of Molecular Medicine</source><volume>29</volume><fpage>1146</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.3892/ijmm.2012.935</pub-id><pub-id pub-id-type="pmid">22427249</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrini</surname><given-names>M</given-names></name><name><surname>Ghezzi</surname><given-names>D</given-names></name><name><surname>Deidda</surname><given-names>G</given-names></name><name><surname>Medrihan</surname><given-names>L</given-names></name><name><surname>Castroflorio</surname><given-names>E</given-names></name><name><surname>Alberti</surname><given-names>M</given-names></name><name><surname>Baldelli</surname><given-names>P</given-names></name><name><surname>Cancedda</surname><given-names>L</given-names></name><name><surname>Contestabile</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>16825</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-17201-8</pub-id><pub-id pub-id-type="pmid">29203796</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescosolido</surname><given-names>MF</given-names></name><name><surname>Ouyang</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Morrow</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss of Christianson Syndrome Na<sup>+</sup>/H<sup>+</sup> Exchanger 6 (NHE6) Causes Abnormal Endosome Maturation and Trafficking Underlying Lysosome Dysfunction in Neurons</article-title><source>The Journal of Neuroscience</source><volume>41</volume><fpage>9235</fpage><lpage>9256</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1244-20.2021</pub-id><pub-id pub-id-type="pmid">34526390</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prekeris</surname><given-names>R</given-names></name><name><surname>Klumperman</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>YA</given-names></name><name><surname>Scheller</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Syntaxin 13 mediates cycling of plasma membrane proteins via tubulovesicular recycling endosomes</article-title><source>The Journal of Cell Biology</source><volume>143</volume><fpage>957</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1083/jcb.143.4.957</pub-id><pub-id pub-id-type="pmid">9817754</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raudvere</surname><given-names>U</given-names></name><name><surname>Kolberg</surname><given-names>L</given-names></name><name><surname>Kuzmin</surname><given-names>I</given-names></name><name><surname>Arak</surname><given-names>T</given-names></name><name><surname>Adler</surname><given-names>P</given-names></name><name><surname>Peterson</surname><given-names>H</given-names></name><name><surname>Vilo</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>W191</fpage><lpage>W198</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz369</pub-id><pub-id pub-id-type="pmid">31066453</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rueden</surname><given-names>CT</given-names></name><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Hiner</surname><given-names>MC</given-names></name><name><surname>DeZonia</surname><given-names>BE</given-names></name><name><surname>Walter</surname><given-names>AE</given-names></name><name><surname>Arena</surname><given-names>ET</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ImageJ2: ImageJ for the next generation of scientific image data</article-title><source>BMC Bioinformatics</source><volume>18</volume><elocation-id>529</elocation-id><pub-id pub-id-type="doi">10.1186/s12859-017-1934-z</pub-id><pub-id pub-id-type="pmid">29187165</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schindelin</surname><given-names>J</given-names></name><name><surname>Arganda-Carreras</surname><given-names>I</given-names></name><name><surname>Frise</surname><given-names>E</given-names></name><name><surname>Kaynig</surname><given-names>V</given-names></name><name><surname>Longair</surname><given-names>M</given-names></name><name><surname>Pietzsch</surname><given-names>T</given-names></name><name><surname>Preibisch</surname><given-names>S</given-names></name><name><surname>Rueden</surname><given-names>C</given-names></name><name><surname>Saalfeld</surname><given-names>S</given-names></name><name><surname>Schmid</surname><given-names>B</given-names></name><name><surname>Tinevez</surname><given-names>JY</given-names></name><name><surname>White</surname><given-names>DJ</given-names></name><name><surname>Hartenstein</surname><given-names>V</given-names></name><name><surname>Eliceiri</surname><given-names>K</given-names></name><name><surname>Tomancak</surname><given-names>P</given-names></name><name><surname>Cardona</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fiji: an open-source platform for biological-image analysis</article-title><source>Nature Methods</source><volume>9</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id><pub-id pub-id-type="pmid">22743772</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott-Solomon</surname><given-names>E</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms of neurotrophin trafficking via Trk receptors</article-title><source>Molecular and Cellular Neurosciences</source><volume>91</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2018.03.013</pub-id><pub-id pub-id-type="pmid">29596897</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skjeldal</surname><given-names>FM</given-names></name><name><surname>Strunze</surname><given-names>S</given-names></name><name><surname>Bergeland</surname><given-names>T</given-names></name><name><surname>Walseng</surname><given-names>E</given-names></name><name><surname>Gregers</surname><given-names>TF</given-names></name><name><surname>Bakke</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The fusion of early endosomes induces molecular-motor-driven tubule formation and fission</article-title><source>Journal of Cell Science</source><volume>125</volume><fpage>1910</fpage><lpage>1919</lpage><pub-id pub-id-type="doi">10.1242/jcs.092569</pub-id><pub-id pub-id-type="pmid">22357949</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Solodkin</surname><given-names>A</given-names></name><name><surname>Gomez</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2012">2012</year><chapter-title>Spinocerebellar ataxia type 6</chapter-title><source>Handbook of Clinical Neurology</source><publisher-name>Elsevier</publisher-name><fpage>461</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-51892-7.00029-2</pub-id><pub-id pub-id-type="pmid">21827907</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>JW</given-names></name><name><surname>Misgeld</surname><given-names>T</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><name><surname>Knecht</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Cotman</surname><given-names>SL</given-names></name><name><surname>Bishop</surname><given-names>DL</given-names></name><name><surname>Lichtman</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Lysosomal activity associated with developmental axon pruning</article-title><source>The Journal of Neuroscience</source><volume>28</volume><fpage>8993</fpage><lpage>9001</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0720-08.2008</pub-id><pub-id pub-id-type="pmid">18768693</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stenmark</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Rab GTPases as coordinators of vesicle traffic</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>10</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1038/nrm2728</pub-id><pub-id pub-id-type="pmid">19603039</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterling</surname><given-names>FR</given-names></name><name><surname>D’Amico</surname><given-names>J</given-names></name><name><surname>Brumfield</surname><given-names>AM</given-names></name><name><surname>Huegel</surname><given-names>KL</given-names></name><name><surname>Vaughan</surname><given-names>PS</given-names></name><name><surname>Morris</surname><given-names>K</given-names></name><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Joyce</surname><given-names>MV</given-names></name><name><surname>Boggess</surname><given-names>B</given-names></name><name><surname>Champion</surname><given-names>MM</given-names></name><name><surname>Maciuba</surname><given-names>K</given-names></name><name><surname>Allen</surname><given-names>P</given-names></name><name><surname>Marasco</surname><given-names>E</given-names></name><name><surname>Koch</surname><given-names>G</given-names></name><name><surname>Gonzalez</surname><given-names>P</given-names></name><name><surname>Hodges</surname><given-names>S</given-names></name><name><surname>Leahy</surname><given-names>S</given-names></name><name><surname>Gerstbauer</surname><given-names>E</given-names></name><name><surname>Hinchcliffe</surname><given-names>EH</given-names></name><name><surname>Vaughan</surname><given-names>KT</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>StARD9 is a novel lysosomal kinesin required for membrane tubulation, cholesterol transport and Purkinje cell survival</article-title><source>Journal of Cell Science</source><volume>136</volume><elocation-id>jcs260662</elocation-id><pub-id pub-id-type="doi">10.1242/jcs.260662</pub-id><pub-id pub-id-type="pmid">36861884</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tate</surname><given-names>BA</given-names></name><name><surname>Mathews</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Targeting the role of the endosome in the pathophysiology of Alzheimer’s disease: a strategy for treatment</article-title><source>Science of Aging Knowledge Environment</source><volume>2006</volume><elocation-id>re2</elocation-id><pub-id pub-id-type="doi">10.1126/sageke.2006.10.re2</pub-id><pub-id pub-id-type="pmid">16807486</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unno</surname><given-names>T</given-names></name><name><surname>Wakamori</surname><given-names>M</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Uchiyama</surname><given-names>Y</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Kubota</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Sasakawa</surname><given-names>H</given-names></name><name><surname>Peters</surname><given-names>C</given-names></name><name><surname>Mizusawa</surname><given-names>H</given-names></name><name><surname>Watase</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6</article-title><source>PNAS</source><volume>109</volume><fpage>17693</fpage><lpage>17698</lpage><pub-id pub-id-type="doi">10.1073/pnas.1212786109</pub-id><pub-id pub-id-type="pmid">23054835</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanier</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Niemann-Pick disease type C</article-title><source>Orphanet Journal of Rare Diseases</source><volume>5</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1172-5-16</pub-id><pub-id pub-id-type="pmid">20525256</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidyadhara</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Chandra</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Role of the endolysosomal system in Parkinson’s disease</article-title><source>Journal of Neurochemistry</source><volume>150</volume><fpage>487</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1111/jnc.14820</pub-id><pub-id pub-id-type="pmid">31287913</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitelli</surname><given-names>R</given-names></name><name><surname>Santillo</surname><given-names>M</given-names></name><name><surname>Lattero</surname><given-names>D</given-names></name><name><surname>Chiariello</surname><given-names>M</given-names></name><name><surname>Bifulco</surname><given-names>M</given-names></name><name><surname>Bruni</surname><given-names>CB</given-names></name><name><surname>Bucci</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Role of the small GTPase Rab7 in the late endocytic pathway</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>4391</fpage><lpage>4397</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.7.4391</pub-id><pub-id pub-id-type="pmid">9020161</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivacqua</surname><given-names>G</given-names></name><name><surname>Renzi</surname><given-names>A</given-names></name><name><surname>Carpino</surname><given-names>G</given-names></name><name><surname>Franchitto</surname><given-names>A</given-names></name><name><surname>Gaudio</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Expression of brain derivated neurotrophic factor and of its receptors: TrKB and p75NT in normal and bile duct ligated rat liver</article-title><source>Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia</source><volume>119</volume><fpage>111</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">25665281</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watase</surname><given-names>K</given-names></name><name><surname>Barrett</surname><given-names>CF</given-names></name><name><surname>Miyazaki</surname><given-names>T</given-names></name><name><surname>Ishiguro</surname><given-names>T</given-names></name><name><surname>Ishikawa</surname><given-names>K</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Unno</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Kasai</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Gomez</surname><given-names>CM</given-names></name><name><surname>Mizusawa</surname><given-names>H</given-names></name><name><surname>Tsien</surname><given-names>RW</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels</article-title><source>PNAS</source><volume>105</volume><fpage>11987</fpage><lpage>11992</lpage><pub-id pub-id-type="doi">10.1073/pnas.0804350105</pub-id><pub-id pub-id-type="pmid">18687887</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>N</given-names></name><name><surname>Kuruvilla</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neurotrophin signaling endosomes: biogenesis, regulation, and functions</article-title><source>Current Opinion in Neurobiology</source><volume>39</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2016.06.004</pub-id><pub-id pub-id-type="pmid">27327126</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaidi</surname><given-names>N</given-names></name><name><surname>Maurer</surname><given-names>A</given-names></name><name><surname>Nieke</surname><given-names>S</given-names></name><name><surname>Kalbacher</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cathepsin D: a cellular roadmap</article-title><source>Biochemical and Biophysical Research Communications</source><volume>376</volume><fpage>5</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.08.099</pub-id><pub-id pub-id-type="pmid">18762174</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Schroeder</surname><given-names>JP</given-names></name><name><surname>Chan</surname><given-names>CB</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>SP</given-names></name><name><surname>Weinshenker</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease</article-title><source>Neuropsychopharmacology</source><volume>39</volume><fpage>638</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1038/npp.2013.243</pub-id><pub-id pub-id-type="pmid">24022672</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The CACNA1A Mutant Disrupts Lysosome Calcium Homeostasis in Cerebellar Neurons and the Resulting Endo-Lysosomal Fusion Defect Can be Improved by Calcium Modulation</article-title><source>Neurochemical Research</source><volume>47</volume><fpage>249</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1007/s11064-021-03438-3</pub-id><pub-id pub-id-type="pmid">34476720</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuchenko</surname><given-names>O</given-names></name><name><surname>Bailey</surname><given-names>J</given-names></name><name><surname>Bonnen</surname><given-names>P</given-names></name><name><surname>Ashizawa</surname><given-names>T</given-names></name><name><surname>Stockton</surname><given-names>DW</given-names></name><name><surname>Amos</surname><given-names>C</given-names></name><name><surname>Dobyns</surname><given-names>WB</given-names></name><name><surname>Subramony</surname><given-names>SH</given-names></name><name><surname>Zoghbi</surname><given-names>HY</given-names></name><name><surname>Lee</surname><given-names>CC</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel</article-title><source>Nature Genetics</source><volume>15</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/ng0197-62</pub-id><pub-id pub-id-type="pmid">8988170</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90510.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chao</surname><given-names>Moses V</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>New York University Langone Medical Center</institution><country>United States</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Compelling</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>This manuscript provides <bold>valuable</bold> insights to the underlying mechanism for Spinocerebellar ataxia 6 (SCA6) due to defective endolysosomal trafficking of BDNF and its receptor TrkB. The findings are <bold>compelling</bold> and significant in understanding the underlying pathology of SCA6. The authors have acknowledged the experimental weaknesses and recognize there may be multiple mechanisms to explain the findings.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90510.3.sa1</article-id><title-group><article-title>Joint Public Review:</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Cook, Watt, and colleagues previously reported that a mouse model of Spinocerebellar ataxia type 6 (SCA6) displayed defects in BDNF and TrkB levels at an early disease stage. Moreover, they have shown that one month of exercise elevated cerebellar BDNF expression and improved ataxia and cerebellar Purkinje cell firing rate deficits. In the current work, they attempt to define the mechanism underlying the pathophysiological changes occurring in SCA6. For this, they carried out RNA sequencing of cerebellar vermis tissue in 12-month-old SCA6 mice, a time when the disease is already at an advanced stage, and identified widespread dysregulation of many genes involved in the endo-lysosomal system. Focusing on BDNF/TrkB expression, localization, and signaling they found that, in 7-8 month-old SCA6 mice early endosomes are enlarged and accumulate BDNF and TrkB in Purkinje cells. Curiously, TrkB appears to be reduced in the recycling endosomes compartment, despite the fact that recycling endosomes are morphologically normal in SCA6. In addition, the authors describe a reduction in the Late endosomes in SCA6 Purkinje cells associated with reduced BDNF levels and a probable deficit in late endosome maturation.</p><p>Strengths:</p><p>The article is well written, and the findings are relevant for the neuropathology of different neurodegenerative diseases where dysfunction of early endosomes is observed. The authors have provided a detailed analysis of the endo-lysosomal system in SCA6 mice. They have shown that TrkB recycling to the cell membrane in recycling endosomes is reduced, and the late endosome transport of BDNF for degradation is impaired. The findings will be crucial in understanding underlying pathology. Lastly, the deficits in early endosomes are rescued by chronic administration of 7,8-DHF.</p><p>Weaknesses:</p><p>The specificity of BDNF and TrkB immunostaining requires additional controls, as it has been very difficult to detect immunostaining of BDNF.</p><p>The revised manuscript has included additional analysis using epitope retrieval and a negative liver control with the Abcam antibody against BDNF. An alternative antibody that may be considered for BDNF detection is from Icosagen AS. This antibody has been found to be effective for immunofluorescence and immunoblot purposes.</p><p>Two other issues were brought up in the initial review process--</p><p>1. One important concern about the conclusions is that the RNAseq experiment was conducted in 12-month-old SCA6 mice suggesting that the defects in the endo-lysosomal system may be caused by other pathophysiological events and, likewise, the impairment in BDNF signaling may also be indirect, as also noted by the authors. Indeed, Purkinje cells in SCA6 mice have an impaired ability to degrade other endocytosed cargo beyond BDNF and TrkB, most likely because of trafficking deficits that result in a disruption in the transport of cargo to the lysosomes and lysosomal dysfunction.</p><p>2. Moreover, the beneficial effects of 7,8-DHF treatment on motor coordination may be caused by 7,8-DHF properties other than the putative agonist role on TrkB. Indeed, many reservations have been raised about using 7,8-DHF as an agonist of TrkB activity. Several studies have now debunked (Todd et al. PlosONE 2014, PMID: 24503862; Boltaev et al. Sci Signal 2017, PMID: 28831019) or at the very least questioned (Lowe D, Science 2017: see Discussion: <ext-link ext-link-type="uri" xlink:href="https://www.science.org/content/blog-post/those-compounds-aren-t-what-you-think-they-are">https://www.science.org/content/blog-post/those-compounds-aren-t-what-you-think-they-are</ext-link> Wang et al. Cell 2022 PMID: 34963057). Another interpretation is that 7,8-DHF possesses antioxidant activity and neuroprotection against cytotoxicity in HT-22 and PC12 cells, both of which do not express TrkB (Chen et al. Neurosci Lett 201, PMID: 21651962; Han et al. Neurochem Int. 2014, PMID: 24220540). Thus, while this flavonoid may have a beneficial effect on the pathophysiology of SCA6, it is most unlikely that mechanistically this occurs through a TrkB agonistic effect considering the potent anti-oxidant and anti-inflammatory roles of flavonoids in neurodegenerative diseases (Jones et al. Trends Pharmacol Sci 2012, PMID: 22980637).</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90510.3.sa2</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cook</surname><given-names>Anna A</given-names></name><role specific-use="author">Author</role><aff><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Leung</surname><given-names>Sophia</given-names></name><role specific-use="author">Author</role><aff><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Rice</surname><given-names>Max</given-names></name><role specific-use="author">Author</role><aff><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Nachman</surname><given-names>Maya</given-names></name><role specific-use="author">Author</role><aff><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Zadigue-Dube</surname><given-names>Elyse</given-names></name><role specific-use="author">Author</role><aff><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib><contrib contrib-type="author"><name><surname>Watt</surname><given-names>Alanna Jean</given-names></name><role specific-use="author">Author</role><aff><institution>McGill University</institution><addr-line><named-content content-type="city">Montreal</named-content></addr-line><country>Canada</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p>Cook, Watt, and colleagues previously reported that a mouse model of Spinocerebellar ataxia type 6 (SCA6) displayed defects in BDNF and TrkB levels at an early disease stage. Moreover, they have shown that one month of exercise elevated cerebellar BDNF expression and improved ataxia and cerebellar Purkinje cell ﬁring rate deﬁcits. In the current work, they attempt to deﬁne the mechanism underlying the pathophysiological changes occurring in SCA6. For this, they carried out RNA sequencing of cerebellar vermis tissue in 12-month-old SCA6 mice, a time when the disease is already at an advanced stage, and identiﬁed widespread dysregulation of many genes involved in the endo-lysosomal system. Focusing on BDNF/TrkB expression, localization, and signaling they found that, in 7-8 month-old SCA6 mice early endosomes are enlarged and accumulate BDNF and TrkB in Purkinje cells. Curiously, TrkB appears to be reduced in the recycling endosomes compartment, despite the fact that recycling endosomes are morphologically normal in SCA6. In addition, the authors describe a reduction in the Late endosomes in SCA6 Purkinje cells associated with reduced BDNF levels and a probable deﬁcit in late endosome maturation.</p></disp-quote><p>We would like to thank the reviewers for their careful reading of the paper, their feedback has helped us to add information and experiments to the paper that enhance the clarity of the ﬁndings.</p><disp-quote content-type="editor-comment"><p>Strengths:</p><p>The article is well written, and the ﬁndings are relevant for the neuropathology of diﬀerent neurodegenerative diseases where dysfunction of early endosomes is observed. The authors have provided a detailed analysis of the endo-lysosomal system in SCA6 mice. They have shown that TrkB recycling to the cell membrane in recycling endosomes is reduced, and the late endosome transport of BDNF for degradation is impaired. The ﬁndings will be crucial in understanding underlying pathology. Lastly, the deﬁcits in early endosomes are rescued by chronic administration of 7,8-DHF.</p></disp-quote><p>We thank the reviewers for their positive feedback on this work.</p><disp-quote content-type="editor-comment"><p>Weaknesses:</p><p>The speciﬁcity of BDNF and TrkB immunostaining requires additional controls, as it has been very diﬃcult to detect immunostaining of BDNF. In addition, in many of the ﬁgures, the background or outside of Purkinje cell boundaries also exhibits a positive signal.</p></disp-quote><p>We agree with the reviewers that the performance of the BDNF and TrkB antibodies is an important concern. We have ourselves had diﬃculties with the performance of many antibodies and the images in this paper are the result of many years of optimization. We have therefore added further detail about the antibody optimization to the methods section of this paper, and have carried out new staining experiments with additional controls. We have added 2 new ﬁgure panels in supplementary ﬁgures 3 and 4 to demonstrate these tests.</p><p>In the case of anti-BDNF antibodies, we have tested several antibodies and staining protocols and found that in our hands, the only antibody that reliably stained BDNF with a good signal to noise ratio was the one used in this paper (abcam ab108319). Even for this antibody, the staining was greatly enhanced by the use of a heat induced epitope retrieval (HIER) step, which allowed the visualization of BDNF within intracellular structures such as endosomes. When we quantiﬁed the intensity of this staining in our previous paper, the results were in agreement with those from a BDNF ELISA used to measure levels of BDNF in the cerebellar vermis of WT and SCA6 mice (Cook et al., 2022), which corroborates these results. As the staining was carried out in tissue sections and not dissociated cells, we also see positive signal from the BDNF staining outside of the Purkinje cells, since BDNF acts on cell-surface receptors and is thus released into the extracellular space around cells (Kuczewski et al., 2008) and is detectable in the extracellular matrix (Lam et al., 2019) and presynaptic terminals around neurons (Camuso et al., 2022; Choo et al., 2017). This is in contrast to studies that image BDNF mRNA with in-situ hybridization, which labels BDNF mRNA predominantly found in cells, and cannot tell us about sub-cellular or extracellular localization of BDNF protein. Together, these factors explain why we observe staining that is not cell- limited, but extends into the space around the cells of interest.</p><p>We have added an additional supplemental ﬁgure to demonstrate the importance of using HIER when staining slices with anti-BDNF (Supplementary ﬁgure 3). We tested HIER protocols that involved heating the slices to 95°C in a variety of buﬀers. The buﬀers tested were sodium citrate buﬀer (10 mM sodium citrate, 0.05% Tween 20, pH 6), Tris buﬀer (10mM TBS, 0.05% Tween 20, pH 10), EDTA buﬀer (1mM EDTA, 0.05% Tween 20, pH 8) and neutral PBS. The PBS produced the best result, enhancing the staining of both anti-BDNF and anti-EEA1 antibodies (Supplementary ﬁgure 3). Therefore all slices stained using those antibodies were heated to 95°C in PBS using a heat block or thermocycler for 10 minutes, then allowed to cool before staining proceeded.</p><p>The antibody we use (abcam ab108319) has been used in hundreds of other publications, including Javed et al., 2021 who ectopically expressed BDNF and noted colocalization between the antibody staining and the GFP tag of the BDNF construct, and Lejkowska et al., 2019 who overexpressed BDNF and saw a dramatic increase in antibody staining as well. The colocalization between ectopically expressed BDNF and the antibody in these studies demonstrates the speciﬁcity of the antibody.</p><p>However, to further validate antibody speciﬁcity we used liver tissue as a negative control. In liver tissue from rodents and humans, the majority of the liver contains negligible levels of BDNF (Koppel et al., 2009; Vivacqua et al., 2014), see also the Human Protein Atlas. The exception is some cholangiocytes: epithelial cells that express BDNF at high levels (Vivacqua et al., 2014). We obtained liver tissue from a WT mouse that was undergoing surgery for an unrelated project and ﬁxed and processed the tissue as we did for brain tissue (outlined in methods section). As we would expect, most of the cells in the liver showed BDNF immunoreactivity that was comparable to background levels (Supplementary ﬁgure 3). Interestingly, we were also able to detect sparse highly BDNF-positive cells in the liver, presumed cholangiocytes (Supp. Fig. 3). This pattern of liver BDNF expression is as predicted in the literature, and thus acts as a control for our antibody. We therefore believe that in our hands this antibody is able to stain BDNF with an appropriate degree of speciﬁcity.</p><p>We also carried out staining experiments using a second anti-TrkB antibody that we had previously used to detect TrkB via Western bloing. We carried out immunohistochemistry as previously described using tissue sections from a WT mouse. The staining with the two diﬀerent antibodies was carried out at the same time and all other reagents were kept constant. We found that both antibodies labelled TrkB in a similar pattern of localization, including in the early endosomes of the Purkinje cells (Supplementary ﬁgure 4). The second antibody however did have a lower signal to noise ratio and so we believe that the original anti-TrkB antibody used in this manuscript (EMD Millipore ab9872) is optimal for staining cerebellar tissue sections in our hands.</p><disp-quote content-type="editor-comment"><p>One important concern about the conclusions is that the RNAseq experiment was conducted in 12-month- old SCA6 mice suggesting that the defects in the endo-lysosomal system may be caused by other pathophysiological events and, likewise, the impairment in BDNF signaling may also be indirect, as also noted by the authors. Indeed, Purkinje cells in SCA6 mice have an impaired ability to degrade other endocytosed cargo beyond BDNF and TrkB, most likely because of traﬃcking deﬁcits that result in a disruption in the transport of cargo to the lysosomes and lysosomal dysfunction.</p></disp-quote><p>We agree with the reviewers that the defects in the endo-lysosomal system may be caused by other events occurring in the course of disease progression. As mentioned by the reviewers, we have noted this possibility in the text. Detailed investigation into the sequence of events and the root causes of signaling disruption in SCA6 merits future study and we aim to address this in future work. We have expanded this explanation in the text.</p><disp-quote content-type="editor-comment"><p>Moreover, the beneﬁcial eﬀects of 7,8-DHF treatment on motor coordination may be caused by 7,8-DHF properties other than the putative agonist role on TrkB. Indeed, many reservations have been raised about using 7,8-DHF as an agonist of TrkB activity. Several studies have now debunked (Todd et al. PlosONE 2014, PMID: 24503862; Boltaev et al. Sci Signal 2017, PMID: 28831019) or at the very least questioned (Lowe D, Science 2017: see Discussion: <ext-link ext-link-type="uri" xlink:href="https://www.science.org/content/blog-post/those-compounds-aren-t-what-you-think-they-are">https://www.science.org/content/blog-post/those-compounds-aren-t-what-you-think-they-are</ext-link> Wang et al. Cell 2022 PMID: 34963057). Another interpretation is that 7,8-DHF possesses antioxidant activity and neuroprotection against cytotoxicity in HT-22 and PC12 cells, both of which do not express TrkB (Chen et al. Neurosci Lett 201, PMID: 21651962; Han et al. Neurochem Int. 2014, PMID: 24220540). Thus, while this ﬂavonoid may have a beneﬁcial eﬀect on the pathophysiology of SCA6, it is most unlikely that mechanistically this occurs through a TrkB agonistic eﬀect considering the potent anti-oxidant and anti-inﬂammatory roles of ﬂavonoids in neurodegenerative diseases (Jones et al. Trends Pharmacol Sci 2012, PMID: 22980637).</p></disp-quote><p>We thank the reviewers for raising this important point. We have noted in our previous paper (Cook et al., 2022) that 7,8-DHF may not be acting as a TrkB agonist in SCA6 mice, and are in agreement that other explanations are possible. We have now added information to the text of this paper to highlight this possibility. We did show in our previous paper that 7,8-DHF administration activates Akt signaling in the cerebellum of SCA6 mice, a signaling event that is known to take place downstream of TrkB activation. Additionally, 7,8-DHF treatment led to the increase of TrkB levels in the cerebellum of SCA6 mice (Cook et al., 2022), implicating TrkB in the mechanism of action, even if mechanistically, this is not via direct TrkB activation alone. However, even if the mechanism is currently incompletely explained, we believe that 7,8- DHF remains a valuable treatment strategy for SCA6. We have tried to rewrite the Discussion to highlight what we think is the most important takeaway: that 7,8-DHF can rescue endosomal and other deﬁcits in SCA6, even if we do not currently know the full mechanism of action. We have therefore amended the text to add more detail about other potential explanations for the mechanism of action of 7,8-DHF.</p><p>References</p><p>Camuso S, La Rosa P, Fiorenza MT, Canterini S. 2022. Pleiotropic eﬀects of BDNF on the cerebellum and hippocampus: Implications for neurodevelopmental disorders. Neurobiol Dis. doi:10.1016/j.nbd.2021.105606</p><p>Choo M, Miyazaki T, Yamazaki M, Kawamura M, Nakazawa T, Zhang J, Tanimura A, Uesaka N, Watanabe M, Sakimura K, Kano M. 2017. Retrograde BDNF to TrkB signaling promotes synapse elimination in the developing cerebellum. Nat Commun 8:195. doi:10.1038/s41467-017-00260-w</p><p>Cook AA, Jayabal S, Sheng J, Fields E, Leung TCS, Quilez S, McNicholas E, Lau L, Huang S, Watt AJ. 2022. Activation of TrkB-Akt signaling rescues deﬁcits in a mouse model of SCA6. Sci Adv 8:3260. doi:10.1126/sciadv.abh3260</p><p>Javed S, Lee YJ, Xu J, Huang WH. 2021. Temporal dissection of Rai1 function reveals brain-derived neurotrophic factor as a potential therapeutic target for Smith-Magenis syndrome. Hum Mol Genet 31:275–288. doi:10.1093/HMG/DDAB245</p><p>Koppel I, Aid-Pavlidis T, Jaanson K, Sepp M, Pruunsild P, Palm K, Timmusk T. 2009. Tissue-speciﬁc and neural activity-regulated expression of human BDNF gene in BAC transgenic mice. BMC Neurosci 10:68. doi:10.1186/1471-2202-10-68</p><p>Kuczewski N, Porcher C, Ferrand N, Fiorentino H, Pellegrino C, Kolarow R, Lessmann V, Medina I, Gaiarsa JL. 2008. Backpropagating action potentials trigger dendritic release of BDNF during spontaneous network activity. J Neurosci 28:7013–7023. doi:10.1523/JNEUROSCI.1673-08.2008</p><p>Lam D, Enright HA, Cadena J, Peters SKG, Sales AP, Osburn JJ, Soscia DA, Kulp KS, Wheeler EK, Fischer NO. 2019. Tissue-speciﬁc extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array. Sci Rep 9. doi:10.1038/s41598- 019-40128-1</p><p>Lejkowska R, Kawa MP, Pius-Sadowska E, Rogińska D, Łuczkowska K, Machaliński B, Machalińska A. 2019. Preclinical Evaluation of Long-Term Neuroprotective Eﬀects of BDNF-Engineered Mesenchymal Stromal Cells as Intravitreal Therapy for Chronic Retinal Degeneration in Rd6 Mutant Mice. Int J Mol Sci 2019, Vol 20, Page 777 20:777. doi:10.3390/IJMS20030777</p><p>Vivacqua G, Renzi A, Carpino G, Franchitto A, Gaudio E. 2014. Expression of brain derivated neurotrophic factor and of its receptors: TrKB and p75NT in normal and bile duct ligated rat liver. Ital J Anat Embryol 119:111–129. doi:10.13128/IJAE-15138</p></body></sub-article></article>